Identifying the Catalytic and Ligand Binding Roles of Active Site Residues in Homotetrameric R67 Dihydrofolate Reductase by Strader, Michael Brad
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Doctoral Dissertations Graduate School 
5-2003 
Identifying the Catalytic and Ligand Binding Roles of Active Site 
Residues in Homotetrameric R67 Dihydrofolate Reductase 
Michael Brad Strader 
University of Tennessee - Knoxville 
Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss 
 Part of the Biochemistry, Biophysics, and Structural Biology Commons 
Recommended Citation 
Strader, Michael Brad, "Identifying the Catalytic and Ligand Binding Roles of Active Site Residues in 
Homotetrameric R67 Dihydrofolate Reductase. " PhD diss., University of Tennessee, 2003. 
https://trace.tennessee.edu/utk_graddiss/2366 
This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee 
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized 
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact 
trace@utk.edu. 
To the Graduate Council: 
I am submitting herewith a dissertation written by Michael Brad Strader entitled "Identifying the 
Catalytic and Ligand Binding Roles of Active Site Residues in Homotetrameric R67 Dihydrofolate 
Reductase." I have examined the final electronic copy of this dissertation for form and content 
and recommend that it be accepted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy, with a major in Biochemistry and Cellular and Molecular Biology. 
Elizabeth E. Howell, Major Professor 
We have read this dissertation and recommend its acceptance: 
Cynthia B. Peterson, Ronald B. Wetzel, Daniel M. Roberts 
Accepted for the Council: 
Carolyn R. Hodges 
Vice Provost and Dean of the Graduate School 
(Original signatures are on file with official student records.) 
To the Graduate Council: 
 
I am submitting herewith a dissertation written by Michael Brad Strader entitled 
"Identifying the Catalytic and Ligand Binding Roles of Active Site Residues in 
Homotetrameric R67 Dihydrofolate Reductase." I have examined the final electronic 
copy of this dissertation for form and content and recommend that it be accepted in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a 
major in Biochemistry and Cellular and Molecular Biology. 
 
 
                Elizabeth E. Howell 
        –––––––––––––––––––––––––––––––––––– 






We have read this dissertation  
and recommend its acceptance: 
 
 
















          Acceptance for the Council: 
 
          Anne Mayhew 
        ____________________________________ 
           Vice Provost and 









Identifying the Catalytic and Ligand Binding Roles of Active Site 






Presented for the 
Doctor of Philosophy 
Degree 







Michael Brad Strader 
May, 2003 
 
   ii
Dedication 
 
This thesis is dedicated to my grandparents 
Abraham and Neva Baughman and Edwardd and Mary-Lea Strader 
who believed in me and were always proud of my accomplsiments 
and 
to my parents 
Jerry and Rosemary Strader 
who provided me with love and guidance 
and 
to my brothers Jason and Gabriel Strader 
who were always there for me with all their love and support 
and 
to my wife  
Ayça Akal-Strader 
Without her love and guidance this would not have been possible  
and 
to my best friends  
Dr. Richard McColl, Dr. Jeffrey Becker, Dr. Barry Bruce, Nathan Verberkmoes,  
Brad Bennett, Chad Bailey, Jason Day and Tony Clicke 
and  
to everyone else who helped along the way. 
   iii
Acknowledgments 
  
 I would like to express my deepest appreciation to my professor, Dr. Elizabeth 
Howell who has always been patient and supportive of abilities.  We have had many 
successful experiences.  While under her direction I have published several papers and 
won several awards.  Even though we did not always see eye to eye, I want to conclude 
my graduate experience by saying that I care very much for her and will always be 
grateful.  I would also like to show gratitude to Dr. Daniel Roberts, Dr. Ron Wetzel and 
Dr. Cynthia Peterson for providing insightful comments and suggestions to my project.  I 
definitely feel privileged to have had them on my committee.  I would also like to 
recognize Dr. Jeffrey Becker, Dr. Barry Bruce, Dr. John Koontz, and Dr. Pete Wicks for 
being supportive in my pursuits.  Each has definitely made a contribution towards my 
education. 
 Finally I would like to express my gratitude to Ayça.  She has really been a major 
source of inspiration and I thank her for being there every step of the way.  It was a tough 








   iv
Abstract 
 
 R67 dihydrofolate reductase (DHFR) is a novel protein that confers clinical 
resistance to trimethoprim (TMP).  Surprisingly, this R-plasmid encoded enzyme does 
not share homology with chromosomal DHFR.  Recently a high resolution crystal 
structure of R67 DHFR has been solved.  From this structure, R67 DHFR is a 
homotetramer that possesses exact 222 symmetry and a single active site pore that 
traverses the length of the protein (Narayana et al., 1995).  Although this symmetry 
implies that four symmetry related binding sites must exist for each substrate, isothermal 
titration calorimetry studies indicate only two molecules bind.  Three possible 
combinations of bound ligands have been observed.  These include two dihydrofolate 
molecules or two NADPH molecules or one substrate + one cofactor (Bradrick et al., 
1996).  The latter is the productive ternary complex.  To date a crystal structure of this 
ternary complex has been solved.  Computational docking studies, however have been 
used to develop a model of the productive ternary complex (Howell et al., 2001).  This 
model has implicated several active site residues to be involved in ligand binding.  
Because of the unusual 222 symmetry of this enzyme and the fact it shares no structural 
similarities with the chromosomal enzyme, R67 DHFR must utilize a different strategy 
for ligand binding and catalysis.  The research in this dissertation has been focused on 
utilizing site directed mutagenesis as a means to probe the function of active residues 
implicated by the computational studies to be important in ligand binding and catalysis.  
Another important goal of this work has been to probe the role interligand cooperativity 
   v
may play in the catalytic function of R67 DHFR.  The results of the research presented in 
this support a model where R67 DHFR utilizes a an unusual “hot spot” binding surface 
capable of binding both ligands and facilitates catalysis simply by binding ligands in the 
appropriate orientation to stabilize the transition state.  Thus R67 DHFR has adopted a 
novel yet simple strategy to reach the transition state compared with other more highly 
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Introduction and Background 
 
 Dihydrofolate reductase (DHFR) catalyzes the NADPH dependent reduction of 
7,8 –dihydrofolate (DHF) to 5,6,7,8 –tetrahydrofolate (THF).  This enzyme catalyzes an 
important step in folate metabolism necessary for maintaining THF cofactors, which are 
1-carbon donors essential for the synthesis of thymidylate, purines and other metabolic 
intermediates.  Because many cellular processes, including DNA synthesis, depend on 
these metabolites, inhibition of DHFR is lethal to dividing cells.  Antifolate reagents such 
as trimethoprim (TMP) and methotrexate (MTX) have an inhibitory effect by binding 
tightly in the active site of DHFR.  These drugs, therefore, are commonly administered 
for the treatment of urinary infections caused by enterobacteria and for certain types of 
cancer (Aymes et al., 1974).  Resistance to these drugs has been attributed to 
overproduction of the enzyme, decreased transport across the cell membrane or 
production of R-plasmid encoded DHFRs that have considerably reduced binding affinity 
(Ki)  for folate analogs (Brisson et al., 1984).  
 
Chromosomal Dihydrofolate Reductases   
 Chromosomal DHFRs contain between 159-189 amino acid residues and are 
monomeric with molecular weights ranging from 18,000 to 22,000 daltons.  Their 
pharmacological and biological significance have made them the subject of intensive 
structural and kinetic studies. High resolution X-ray crystal structures for DHFR from 
several species have been determined for several binary and ternary complexes as well as 
for the apoenzyme (Bystroff et al., 1990; Bolin et al., 1982; Sawaya and Kraut, 1997).  
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Despite the fact that mammalian and bacterial DHFRs share only 25% sequence 
homology, X-ray crystallography indicates remarkable structural similarities.  For 
example, crystal structures of both E.coli and mammalian DHFR indicate nearly identical 
monomeric structures composed of an 8 stranded β sheet with 4 major connecting α 
helices (McTigue et al., 1992; Filman et al., 1982; Bolin et al., 1982; Bystroff and Kraut, 
1990). Interestingly, DHFRs exhibit strong species selectivity for antifolate drugs 
regardless of their high levels of structural homology.  The most significant example is 
that of trimethoprim (TMP), which selectively inhibits bacterial DHFRs, while only 
weakly affecting mammalian DHFR.  The TMP affinity for E.coli DHFR is 
approximately 10,000 times higher than that exhibited for the human enzyme (Stone and 
Smith, 1979).   
 
R-Plasmid Encoded DHFRs 
 R-plasmids carrying TMP resistance discovered in 1972, confer a high level of 
resistance to TMP in Escherichia coli, Klebsiella aerogenes and other gram negative 
bacteria.  This resistance was originally thought to be due to either alteration of TMP to 
an inactive form or through decreased transport of folate analogs across the cell 
membrane.  Later studies indicated that the observed TMP resistance was due to the 
presence of a second species of dihydrofolate reductase (Aymes et al., 1974).  
Interestingly, these novel R-plasmid encoded DHFRs were found to be fully active in the 
presence of TMP concentrations that would completely inhibit chromosomal DHFR.  
Such a discovery was of interest because it could involve an oxidoreductase that allows 
the chromosomal DHFR to be bypassed (Aymes et al., 1989). The question researchers 
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began addressing was: how do these novel R-plasmid encoded DHFRs differ in both 
structure and catalytic strategy from those of chromosomal DHFRs?      
Seventeen different types of R plasmid encoded DHFRs (designated I-XVII) have 
currently been identified (White et al., 2001).  All share the feature of conferring TMP 
resistance but differ in the degree and type of resistance they impart.   With the exception 
of types III and IV, all types are TMP insensitive as a result of reduced affinity for the 
inhibitor.  The TMP affinities of these DHFRs are 104 to 106 less than that of the 
chromosomal enzyme (Aymes et al., 1989).  The type III R-plasmid encoded DHFR 
binds TMP with an affinity only 50 fold less than that of the chromosomal enzyme.  
Furthermore the kinetic data indicate tighter substrate binding (DHF Km is lower) than 
chromosomal DHFR.  Taken together, the TMP resistance displayed by the type III 
enzyme is a combination of tighter substrate binding and only marginally weaker 
inhibitor affinity (Joyner et al., 1984).  The type IV TMP resistance mechanism is unique 
in that higher levels of enzyme expression are induced in the presence of increasing 
inhibitor concentrations (Young et al., 1986).  
With the exception of the type II enzyme, R-plasmid encoded DHFRs share high 
levels of sequence homology with the E. coli chromosomal DHFR.  These highly 
conserved regions correspond to functional amino acid sequences essential for substrate 
and cofactor binding in the chromosomal enzyme.  Such homology suggests an 
evolutionary relationship with chromosomal DHFR.  Type II R plasmid DHFRs, on the 
other hand, represent the only group that do not share structural or genetic similarities 
with any chromosomal DHFR studied, making them very unique and interesting.  These 
enzymes also provide the highest level of resistance of the R-plasmid encoded DHFRs, 
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possessing a TMP Ki in the millimolar range. This value differs by a factor of 106 when 
compared to the Ki for E. coli chromosomal DHFR (Aymes et al., 1989).  Although the 
Km values for substrate and cofactor are similar between the type II R plasmid encoded 
DHFR and the E.coli chromosomal DHFRs, the rate of hydride transfer for the type II 
enzyme is about 100 fold less than that for the E.coli chromosomal DHFR (Reece et al., 
1991; Joyner et al., 1984).  A prerequisite for hydride transfer from NADPH to DHF is 
the addition of a proton at N5 of DHF.  In the E.coli chromosomal DHFR, Asp 27 has 
been proposed to be a proton donor that facilitates the rate of catalysis (Howell et al., 
1986).  A functional residue that might serve as a proton donor for facilitating hydride 
transfer has not been identified for type II DHFRs.  These unique properties have made 
type II DHFRs the most interesting of the R plasmid encoded enzymes.   
 
Type II DHFRs 
 Although the exact origin of the type II plasmid encoded DHFR remains obscure, 
the lack of structural and sequence homology rules out the possibility that it 
evolutionarily diverged from chromosomal DHFR.   Perhaps this enzyme was originally 
an oxidoreductase unrelated to the chromosomal counterpart.  In such a scenario, 
selective pressure may have resulted in losing specificity for an earlier substrate while 
acquiring the capacity to reduce dihydrofolate.  Alternatively, it may also serve as a 
model for a primitive enzyme (Narayana et al., 1995).    
 Three type II R-plasmid encoded DHFR variants have been discovered.  These 
include R67, R388, and R751 (Aymes and Smith et al., 1976; Pattishall et al., 1977; 
Broad et al., 1982).  Each share nearly identical amino acid sequences with the exception 
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of the first 21 residues of the N-terminus.  Such a high level of conservation indicates the 
essential role the last 57 amino acids play in both structure and catalytic strategy (Brisson 
et al., 1984).  This idea is supported by the fact that native R67 DHFR, in which the first 
16 amino acids of the NH2-terminus are proteolytically cleaved off, is fully active (Reece 
et al., 1991). 
Several sources of data, including gel filtration and a crystal structure of R67 
DHFR resolved at 1.7 Å resolution indicate that type II plasmid DHFRs are tetramers 
composed of four identical subunits. The molecular weight of each subunit is 8,430 
daltons (Smith et al., 1979).  The type II gene encodes a monomer composed of 78 amino 
acids that spontaneously associates with three equivalent monomers to form the active 
enzyme (Zolg et al., 1981). 
   
R67 DHFR Structure  
 The first reported crystal structure of R67 DHFR was a dimer. From this 
structure, weak diffuse electron density was observed for the N-terminal 17 amino acids. 
This highly disordered sequence of amino acids did not appear to be essential in 
stabilizing the tertiary structure (Matthews et al., 1986).  After several failed attempts to 
produce crystals of tetrameric R67 DHFR, chymotrypsin was utilized to selectively 
truncate the full length protein after Phe 16.  The truncated form resulted in an X-ray 
crystal structure of the fully active homotetramer at 1.7 Å resolutiuon.  The truncated 
enzyme consists of four β barrel subunits that crystallize to form a tetramer with exact 
222 symmetry (Narayana et al., 1995). 
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  The structure of tetrameric R67 DHFR is illustrated in Figure 1.  Each monomer 
folds to form an up and down six stranded β barrel with the fifth strand missing. In this 
compact structure, three short loops and a turn of 310 helix connect individual β strands. 
The structurally identical monomers come together to form an active tetramer that is 
stabilized by two monomer-monomer and two dimer-dimer interfaces (Narayana et al., 
1995).  
Each monomer-monomer interface is stabilized by intersubunit β barrel 
formation.  This involves symmetrically identical strands B, C and D from one subunit 
coming together with the corresponding strands of a second subunit to form a third β 
barrel at the interface. Several interactions are involved in stabilizing the formation of 
dimers at the two monomer-monomer interfaces.  These include hydrophobic packing of 
side chains within the interior of the intersubunit β barrel, antiparallel β sheet hydrogen 
bonding between symmetrically related β strands and van der Waals interactions between 
the side chains of symmetrically related Met 26 residues (Narayana et al., 1995). 
The active tetramer is stabilized at the two dimer-dimer interfaces by several 
interactions involving symmetrically related histidines 62, 162, 262 and 362.  Among the 
most important of these interactions are hydrogen bonding and hydrophobic stacking 
between imidazole sidechains, and hydrogen bonding with serines 59, 159, 259 and 359 
(Nichols et al., 1991; Dam et al., 2000).  Protonation of these histidine residues 










Figure 1: Ribbon diagram of tetrameric R67 DHFR taken from the structure of 
Narayana, N., Matthews, D.A., Howell, E.E., and Xuong, N.H. (1995) Nat. Struct. Biol. 
2, 1018-1025.  The structure is viewed down the center of the central pore.  The side 
chains of the symmetry-related histidine 62 and glutamine 67 residues are shown at the 
dimer-dimer interface.  Each monomer is clarified by a different color.   Residues 17 - 78 
correspond to the first monomer, 117 - 178 correspond to the second monomer, 217 - 278 
correspond to the third monomer and 317 - 378 correspond to the fourth monomer.   
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been found to reversibly dissociate into inactive dimers.  This most likely results from 
juxapositioning positively charged imidazoles next to each other (Nichols et al., 1993).  
Other forces that play a role in tetramer stabilization are interactions between residues in 
the loop connecting ß strands C and D (60-65) and four residues just proceeding strand B, 
stacking interactions between Trp 38, 138, 238, and 338, van der Waals interactions at 
the interface of the dimers and the formation of hydrogen bonds between symmetry 
related Gln 67 residues (Narayana et al., 1995). 
  R67 DHFR is a dimer of dimers that shows exact 222 symmetry.  180° rotation 
along the x, y, or z axes results in a symmetrically identical molecule.  Each subunit 
interacts through the two different interfaces to form a toroidal shaped homotetramer 
possessing an unusual central pore.  The reported crystal structure indicates this elliptical 
pore spans the entire length of the enzyme which is approximately 25Å.  The mouth of 
the pore measures 24 X 18Å and reduces in size by half at the center due to side chain 
interactions from four symmetrically related glutamine 67 residues directed into the pore 
(see Figure 1).  These side chains form hydrogen bonds in pairs, creating a floor and 
ceiling in the active site.   
Fourier maps of crystallized R67 DHFR complexed with 2 asymmetrically bound 
folates indicate the central pore to be the active site.  In addition, this binary complex is 
isomorphous with the apoenzyme suggesting ligand induced conformational changes do 
not occur.  This data, taken together with the observed 222 symmetry of tetrameric R67 
DHFR, suggests the active site pore is composed of symmetry related binding surfaces 
from all four structurally identical monomers (Narayana et al., 1995; Bradrick et al., 
1996). 
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Oligomeric States of R67 DHFR  
 The oligomeric state of R67 DHFR in solution depends primarily on pH.  Nichols 
et al. (1993) performed sedimentation equilibrium, gel filtration and steady state 
tryptophan fluorescence studies and concluded R67 DHFR is tetrameric at pH 8 and 
dimeric at pH 5.  Symmetrically related tryptophans W38, W138, W238 and W338 occur 
at the dimer-dimer interface, and allow alterations in the tetramer-dimer equilibrium to be 
monitored as W38 moves from a hydrophobic (tetramer) to a hydrophilic (dimer) 
environment. This behavior arises as the W38 fluorescence emission spectra are sensitive 
to the polarity of their environment.  When fluorescence was monitored over the pH 
range 5-8, a protein concentration dependence of fluorescence was observed and global 









where T is tetrameric, D and DHn are dimeric forms of unprotonated and protonated R67 
DHFR and Koverall = (Ka)2n/Kd.  The pKa of 6.84 corresponds to the titration of 
symmetrically related histidines 62, 162, 262 and 362.  The crystal structure of tetrameric 
R67 DHFR indicates the active tetramer to be stabilized by several interactions involving 
Koverall
2nH+ 





(see previous section) symmetrically related histidine 62 residues (see Figure 1).  
Ionization of H62 destabilizes tetrameric R67 DHFR most likely because of 
juxapositioning positively charged imidazoles next to each other (Nichols et al., 1993).   
A recent study by Park et al. (1997) involving the construction of an H62C mutant 
also indicated the important role symmetrically related histidines 62 residues play in 
stabilizing the dimer-dimer interface. This mutant allows disulfide cross linking at the 
dimer-dimer interfaces. The two dimers were covalently linked to form an active tetramer 
that did not dissociate into inactive dimers upon reduction of pH.  Because disulfide 
cross-linking requires that cysteine side chains be in close proximity, these results 
provide further evidence that symmetrically related histidine 62 residues stabilize the 
active tetramer through interactions with each other. 
 
Mechanism of catalysis 
   Catalysis in R67 DHFR occurs when NADPH binds near the center of the pore 
and reduces a bound substrate molecule (Narayana et al., 1995).  The stereospecificity of 
this reaction involves hydride transfer from carbon 4 of the nicotinamide ring of NADPH 
(See Figure 2) to carbon 6 of the si face of the dihydrofolate pteridine ring (Matthews et 
al., 1986).  The 222 symmetry of R67 DHFR dictates that for each binding site, there 
must be three symmetry related sites generated by 180° rotations along the x, y, and z 
axes.  Binding studies using isothermal titration calorimetry and time resolved anisotropy 
techniques, however, indicate that only two molecules bind concurrently, most likely due 




















Figure 2.  The structures of folate and NADPH.  Reduction of folate across the C7-N8 
bond yields dihydrofolate.  During catalysis, the A or re hydrogen (HR) on C4 of the 
nicotinamide ring faces the si face of the folate pteridine ring, which accepts a hydride at 
C7.  The hydride would approach the si face of the pteridine ring from beneath the plane 
of the paper.  The NMN (nicotinamide ribose P1) moiety of NADPH is indicated by the 
bracket.  Taken from Howell E.E., Shukla, U., Hicks N.S., Smiley R.D., Kuhn A.L., & 



























































































The combinations of bound molecules include two substrates (dihydrofolate or folate), 
two cofactors (NADPH), or one substrate and one cofactor. The latter is the productive 
complex while the first two are non-productive complexes which block the active site 
pore.  Binding of two NADPH molecules displays negative cooperativity while binding 
of two DHF molecules displays positive cooperativity (Bradrick et al., 1996).  
Comparison of the crystal structure for the apoenzyme and the folate binary complex 
clearly shows that changes in protein conformation do not occur upon ligand binding 
(Narayana et al., 1995).  The different observed cooperativities for cofactor and substrate 
are, therefore, most likely induced by ligand -ligand interactions.  The observed negative 
cooperativity for cofactor could occur if NADPH binds near to or at the center of the pore 
such that binding of a second molecule, in a symmetrically related site, is inhibited by 
steric or electrostatic effects.  Positive cooperativity for the substrate possibly can be 
described by weak binding of the first molecule followed by ligand-ligand interactions 
that facilitate tight binding of the second DHF.  A proposed binding mechanism 
describing catalysis is shown in Figure 3.  Although a random addition mechanism for 
bound ligands might be expected, the positive and negative cooperativity patterns serve 
to establish a productive catalytic channel where free enzyme binds cofactor first 
followed by substrate to form the productive ternary complex (Bradrick et al., 1996). 
 Studies have shown that both hydride transfer from the C4 carbon of NADPH to 






















Figure 3.  Proposed binding mechanism for R67 DHFR taken from Bradrick, T.D., 
Beechem, J.M. & Howell, E.E. (1996) Biochemistry  35:11414-11424.  This mechanism 
is based on data obtained from time resolved fluorescence anisotropy and isothermal 
titration calorimetry experiments. The mechanism clearly shows a preferred pathway 
(shown in bold) in which NADPH binds first followed by DHF. 
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E
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E   DHF
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Kd = 8.8 µM
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components of catalysis.  The actual sequence of hydride transfer and N5 protonation has 
not been clarified.  In the E.coli chromosomal DHFR, Asp 27 has been proposed to be a 
proton donor that greatly increases the rate of catalysis (Howell et al., 1986).  In contrast 
to chromosomal DHFRs, which have a conserved carboxylic acid side chain for 
protonating substrate at N5 prior to hydride transfer from NADPH, no proton donor has 
been identified for R67 DHFR.  This indicates that reduction of the N5-C6 double bond 
in DHF requires extracting a proton from the solvent and that the actual substrate for R67 
DHFR is protonated DHF (pKa = 2.59) (Maharaj et al., 1990; Park et al., 1997). 
 Evidence supporting the hypothesis that preprotonated DHF can serve as a 
substrate was found in site-directed mutagenesis studies using an E.coli chromosomal 
DHFR mutant in which the active site proton donor Asp 27 was  mutated to asparagine 
(D27N).  The mutant had about 1/300th the activity of wildtype DHFR at neutral pH and 
an increase in the rate of reduction of DHF was observed as the pH was lowered (Howell 
et al., 1986).  This was proposed to result from increasing the concentration of protonated 
DHF in solution as the pH was lowered (pKa of N5 in DHF is 2.59, Maharaj et al., 1990).   
 The H62C mutant constructed by Park et al. (1997) in which two dimers are 
covalently linked, does not dissociate into inactive dimers upon reducing the pH. In this 
mutant, the pH profile for kcat shows an increasing rate as the pH is decreased, supporting 
the hypothesis that the actual substrate for R67 DHFR is protonated DHF.  This is unlike 
the bell shaped pH profile for wildtype R67 DHFR, which contains an apparent acidic 
pKa that is protein concentration dependent (Park et al., 1997).  The acidic pKa 
corresponds to dissociation of active tetramer into relatively inactive dimers.  This 
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titration masks any pKa corresponding to the use of protonated DHF as substrate in which 
becomes visible in the H62C mutant.  
 
Binding Surface of the Active Site Pore 
 The 222 symmetry of R67 DHFR dictates that each monomer contributes equally 
to form the ligand binding surface in the central pore.  Residues that contribute to this 
surface therefore possess three symmetry related partners generated by 180º rotations 
along the x, y and z axes.  Although, a total of 17 residues from each subunit are involved 
in forming the pore surface, 43% of the surface area is composed of the surfaces derived 
from residues S65, V66, Q67, I68 and Y69.   
Figure 4 shows the solvent accessible Connolly surface of R67 DHFR with these 
residues in the active site pore highlighted in color.  A basic trend seen from analyzing 
the central pore surface is that residues near the center of symmetry (Q67 and I68) 
interact in pairs while residues further away (S65, V66 and Y69) form individual binding 
surfaces.  For example, two Q67 residues form hydrogen bonds with each other at the 
“floor” of the active site, while the other two symmetry-related Q67 residues form a 
similar hydrogen bonding pair at the “ceiling” of the pore.  Residues S65, V66 and Y69 
do not pair up with symmetry related residues to form 2 contiguous surfaces as Q67 does.  
Q67 has been proposed to form extensive van der Waals interactions with the pteridine 
ring of folate in the R67-DHFR-folate crystal structure (Narayana et al., 1995).  
Similarly, two sets of symmetrically related I68 residues form the right and left hand 
sides of the pore.  The backbone NH group of I68 is proposed to be involved in hydrogen 
































Figure 4: The connolly surface of R67 DHFR.  Panel A shows the entire tetramer, with 
the residues in the active site pore highlighted in color.  The image in Panel B shows the 
tetramer cut in half along the monomer-monomer interfaces; thus the dimer-dimer 
interfaces are intact (only one interface is shown).  The orientation is related to that 
shown in Panel A by 90º rotation along the x-axis.  The large, continuous orange patch in 
the center arises from two interacting Q67 residues.  Panel C shows the tetramer cut in 
half along the dimer-dimer interfaces, generating intact monomer-monomer interfaces 
(only one interface is shown).  This orientation is generated from Panel A by a 90º 
rotation along the y-axis.  The large, continuous red patch in the center arises from two 
interacting I68 residues.  Color codes are as follows: K32, dark blue; A36, brick red Y46, 
magenta; T51, grey; G64, light blue; S65, light pink; V66, yellow; Q67, orange; I68, red; 










symmetry-related I68 residue is proposed to interact with N8 of folate through a 
conserved water molecule (water 124).  V66, S65 and Y69 are positioned further away 
from the center of symmetry; but all possess side chains oriented toward the center of the 
pore and may be involved in hydrogen bond interactions.  Interestingly, the crystal 
structure of the binary complex with two folates indicates that the backbone carbonyl 
oxygen of V66 positions an ordered water molecule within hydrogen bonding distance of 
N5 which could provide a stabilizing interaction. 
 
Computational Model of Productive Ternary Complex 
 A model for bound NADPH was initially proposed by Narayana et al. using the 
folate-R67 co-crystal structure (two folates and one NADPH), however subsequent ITC 
binding data indicated that it must be incorrect as only 2 ligands bind.  A more recent 
computational docking study using DOCK (Kuntz et al., 1982; Shoichet, B. K and Kuntz, 
I.D., 1993) and SLIDE (Schnecke et al., 1999; Raymer et al., 1997) has been used to 
predict roles for residues composing the active site pore surface (Howell et al., 2001).  
Dock utilizes van der Waals interactions for docking of flexible ligands, while SLIDE 
includes protein side-chain flexibility, full ligand flexibility, probabilistic inclusion of 
active-site bound water molecules, and a scoring function with hydrophobic interaction 
and hydrogen bond terms.  In the original crystal structure solved by Narayana et al. 
(1995), fitting the electron density resulted in two folate molecules modeled in 
asymmetric positions.  FOL1 bound productively in an extended conformation with its si  
face exposed, whereas FOLII bound with its si face nestled against the side of the pore  
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and unavailable to receive a hydride.  The bound pteridine ring of folate (FOL1) from the 
crystal structure was, therefore, used as a starting complex for docking the nicotinamide-  
ribose-PI moiety (NMN) of NADPH.  Figure 5 shows the top scoring orientations of the 
NMN fragment docked into the R67 DHFR-FOL1 complex using DOCK (Howell et al., 
2001).  The NMN orientations in this figure satisfy the stereochemistry required for 
hydride transfer from carbon 4 of the nicotinamide ring of NADPH to carbon 5 of the si 
face of the dihydrofolate pteridine ring (Matthews et al., 1986).  The highest scoring 
conformers from both DOCK and SLIDE were similar and provided a model for the 
ternary complex.  From the various docked ligands, several of the residues are proposed 
to play a dual role in binding.  These include A36, Y46, V66, Q67, I68 and Y69.   
 
Specific Aims 
 The E.coli chromosomal DHFR has an evolved active site containing specific 
regions for binding either DHF or NADPH.  For example, mutations in the DHF binding 
pocket substantially affect DHF binding without effecting NADPH and vice versa (Miller 
and Benkovic 1998).  These results indicate the effects of the mutations are mostly local 
and focus on the ligand whose contact has been disrupted.  In such a scenario, lesser to no 
effects are observed on binding of the second ligand.   
 The 222 symmetry of the active R67 DHFR tetramer combined with the present 
computational model of the ternary complex suggest very different ligand binding and 
catalytic strategies.  The purpose of the research described in this dissertation is to 
evaluate the role of residues located in the active site pore proposed to be involved in 

















Figure 5:  Orientation of the NMN fragment docked into the R67 DHFR-FOL 1 complex 
using DOCK.  The eight top scoring candidates that satisfy the stereochemistry of the 
reaction are shown.  Fol1 lies at the bottom right of the image, while the docked NMN 
molecule lies at the top left.  Atoms are colored according to chemical properties where 
carbon is green, oxygen is red, nitrogen is blue and hydrogen is white.  The 
stereospecificity  of this reaction  involves hydride transfer from the carbon 4 A(re) 
hydrogen of the nicotinamide ring of NADPH to carbon 7 of the si face of the folate 
pteridine ring. Taken from Howell E.E.,  Shukla, U., Hicks N.S., Smiley R.D., Kuhn 











strategy and catalysis this enzyme uses compared to those of chromosomal DHFR.  
Several mutant R67 DHFR genes have been constructed and their role in binding 
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Abstract 
 R67 dihydrofolate reductase (DHFR) shares no sequence or structural homology 
with chromosomal DHFRs.  This enzyme arose recently in response to the clinical use of 
the antibacterial drug, trimethoprim.  R67 DHFR is a homotetramer possessing a single 
active site pore.  A high resolution crystal structure shows the homotetramer possesses 
exact 222 symmetry (Narayana et al., 1995).  This symmetry dictates four symmetry 
related binding sites must exist for each substrate as well as each cofactor.  Isothermal 
titration calorimetry studies, however, indicate only two molecules bind: either two 
dihydrofolate molecules or two NADPH molecules or one substrate + one cofactor 
(Bradrick et al., 1996).  The latter is the productive ternary complex.  To evaluate the role 
of S65, Q67, I68 and Y69 residues, located near the center of the active site pore, site 
directed mutagenesis was performed.  One mutation in the gene creates four mutations 
per active site pore which typically result in large cumulative effects.  Steady state kinetic 
data indicate the mutants have altered Km values for cofactor and substrate.  For example, 
the Y69F R67 DHFR displays an 8 fold increase in the Km for dihydrofolate and a 22 fold 
increase in the Km for NADPH.  Residues involved in ligand binding in R67 DHFR 
display very little, if any, specificity, consistent with their possessing dual roles in 
binding.  These results support a model where R67 DHFR utilizes an unusual “hot spot” 
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binding surface capable of binding both ligands and indicate this enzyme has adopted a 
novel, yet simple approach to catalysis. 
 
Introduction 
 Dihydrofolate reductase (DHFR) reduces dihydrofolate (DHF) to tetrahydrofolate 
using NADPH as a cofactor.  It catalyzes an important step in folate metabolism since 
tetrahydrofolate is involved in the synthesis of thymidylate, purine nucleosides, 
methionine, and other metabolic intermediates.  DHFR is a target for clinically important 
drugs such as methotrexate and trimethoprim since efficient inhibition of its activity 
culminates in blockage of DNA synthesis and cell death.  
Trimethoprim (TMP), an active site directed inhibitor of chromosomally encoded 
bacterial DHFRs, is used to treat bacterial infections.  Resistance to trimethoprim (TMP) 
has been observed and correlated with the production of novel DHFRs encoded by R-
plasmids.  Type II R-plasmid encoded R67 DHFR is genetically and structurally 
unrelated to chromosomal DHFRs, thus a comparison of its properties with chromosomal 
DHFR can elucidate differences in their catalytic strategies. 
R67 DHFR was initially crystallized as a dimer (Matthews et al., 1986).  More 
recently, a crystal structure of the active homotetramer was reported, both as an apo 
enzyme and as a binary complex with folate (Narayana et al., 1995).  Each monomer of 
R67 DHFR possesses a five-stranded β barrel fold that has subsequently been identified 
as occurring in SH3 domains.  The R67 DHFR tetramer displays a toroidal shape with a 
pore that traverses the length of the protein.  This pore has been identified as the active 
site by difference Fourier maps describing bound folate.  While a shared active site 
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between protomers is not surprising, only one active site per oligomer is quite unusual. 
Other examples of one binding site per oligomer include the AIDS protease (Wlodawer et 
al., 1989), 3,5,3’,5’-tetraiodo-L-thyronine (T4) binding to transthyretin (Wojtczak et al.,  
2001) and bisphosphoglycerate binding to the central pore in hemoglobin (Arnone et al., 
1972). 
A 222  symmetry operator occurs at the center of the active site pore; this dictates 
that for each binding site, there must be three symmetry related sites generated by 180o 
rotations along the x, y and z axes.  Once a ligand binds however, then R67 DHFR no 
longer possesses 222 symmetry.  Providing the asymmetry does not affect lattice 
interactions, overall 222 symmetry in the crystal can still be preserved by disordering 
where the asymmetric molecules randomly occupy the four symmetry related binding 
sites.  This situation describes the R67 DHFR•folate complex (Narayana et al.,1995).  
Difference maps for bound folate show low density in the pore and describe overlapping 
density from 2 folate molecules bound in two asymmetric sites (Fol1 and Fol2), each at ¼ 
occupancy. 
Our binding studies using isothermal titration calorimetry (ITC) show only 2 
molecules bind concurrently, most likely due to steric constraints.  The combinations of 
bound molecules include two substrates (dihydrofolate/folate) or two cofactors (NADPH) 
or one substrate plus one cofactor (Bradrick et al., 1996).  The latter is the productive, 
ternary complex.  Cofactor inhibition is not typically observed (within the range of assay 
concentrations used) as negative cooperativity occurs between two bound NADPH 
molecules (macroscopic Kd values of 2.5 and 95 µM).  Substrate inhibition is also not 
typically observed as positive cooperativity between two bound dihydrofolate molecules 
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occurs (macroscopic Kd values of 125 and 8.8 µM).  This model indicates each half-pore 
can accommodate either DHF/folate or NADPH, presumably with different orientations. 
Serine 65 (S65), glutamine 67 (Q67), isoleucine 68 (I68) and tyrosine 69 (Y69), 
as well as their symmetry related residues, occur near the center of the active site pore 
and contribute substantially to the surface as shown in Figure 1.  Residues near the center 
of symmetry interact with each other in pairs (Q67 and I68), while residues further away 
from the symmetry operator form individual binding surfaces (S65 and Y69).  For 
example, two Q67 residues form hydrogen bonds with each other at the “floor” of the 
active site while the other two symmetry related Q67 residues form a similar hydrogen 
bonding pair at the “ceiling” of the pore.  Q67 has been proposed to form extensive van 
der Waals interactions with the pteridine ring of folate in the R67 DHFR•folate crystal 
structure (Narayana et al., 1995).  Density for only the pteridine ring of folate was 
observed, suggesting the p-aminobenzoic acid -glu tail is disordered. Two I68 residues 
also interact with each other on the “right hand side” of the pore as well as a symmetry 
related pair on the “left hand side” of the pore.  The backbone NH- group of I68 is 
proposed to be involved in hydrogen bonding to the 4-oxo group of folate.  In addition, 
the backbone NH- of a symmetry related I68 residue is proposed to interact indirectly 
with the N8 of folate through water molecule 124.  A possible role for partial exclusion 
of solvent during catalysis may also be associated with I68.  S65 and Y69 lie further out 
from the 222 symmetry operator, thus the binding surface contributed by each of the four 
symmetry related residues is separate (i.e. they do not pair up with a symmetry related 
S65 or Y69 residue on the active site pore surface to provide two contiguous surfaces as 








Figure 1.  A stereo drawing of the active site pore in R67 DHFR.  The Fol1 molecule 
was obtained from the 1VIF file from the protein data bank.  The NMN molecule was 
docked into the R67 DHFR•Fol1 complex using DOCK (Howell et al., 2001).  Residues 
65-69 are labeled for one monomer (bottom right).  The same residues repeat 3 additional 
times due to the 222 symmetry.  A second Q67 residue is labeled at bottom left; a second 
I68 residue is labeled at the right middle.  Green denotes carbon atoms; blue, nitrogen 








however the hydroxyls from their sidechains are pointing toward the pore and could be 
candidates for hydrogen bond formation.   
Specific interactions between R67 DHFR and cofactor have not been observed in 
a co-crystal structure, however reduction of the pteridine ring by the nicotinamide ring of 
NADPH would require the NMN moiety (nicotinamide-ribose-Pi) to bind near the center 
of the pore.  A model for bound NADPH was initially proposed by Narayana et al; 2 
folates + 1 NADPH, however subsequent ITC binding studies indicated it must be 
incorrect as only 2 ligands bind (Bradrick et al., 1996).  A more recent computational 
docking study using DOCK (docking based on van der Waals interactions; Kuntz et al., 
1982; Shoichet et al., 1993) and SLIDE (docking based on H-bond formation;  Schnecke 
et al., 1999; Schnecke et al., 1998; Raymer et al., 1997) predicts roles for all four residues 
in binding NMN (Howell et al., 2001).  Briefly, the hydroxyl group of S65 may form a 
hydrogen bond (through an intermediary water molecule) to one of the ribose OHs (O2’) 
as well as to one of the oxygens of the Pi (O2) in NMN.  Q67 may form a H bond to one 
of the ribose OHs (O2’) through its NE2 group as well as form van der Waals interactions 
with several atoms of the nicotinamide ring through its sidechain.  I68 may form a pair of 
H bonds between its backbone NH and O groups with the O and NH2 of the carboxamide 
moiety of the nicotinamide ring, respectively.  Several van der Waals interactions are also 
predicted between I68 and the ribose and Pi groups.  The OH of Y69 may form a H-bond 
(through an intermediary water) to an oxygen off the Pi group.  Y69 may also form 
several van der Waals interactions through its CD1 and CE1 atoms with the ribose OHs.  
Howell et al. (2001) propose numerous residues in R67 DHFR play a dual role in 
binding.  For example, Q67 from both the B and D subunits has several contacts with the 
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pteridine ring of substrate, while Q67 from the A and C subunits has several predicted 
contacts with the nicotinamide ring of cofactor (see Figure 1).  Other residues proposed 
to be involved in binding both ligands are I68 and Y69.  This plasticity in binding is 
proposed to form a “hot spot” binding surface and allows an unusual mechanism for 
ligand binding and catalysis.  Hot spots for protein-protein interactions have been noted 
and evaluated by mutagenesis and statistical analysis (Delano et al., 2000; Bogan et al., 
1998; Hu et al., 2000).  A general trend proposed is the presence of residues that are 
amphipathic.  To evaluate the role of S65, Q67, I68 and Y69 residues in binding 
specificity as well as catalysis, mutant R67 DHFR genes were constructed and the effects 
of the mutations assessed. 
   
Materials and Methods 
 
Construction and Expression of Mutant R67 DHFRs   
A synthetic R67 gene, carried in pUC8, has been previously described (Reece et 
al., 1991).  Site directed mutagenesis using the appropriate primers was employed to 
construct S65A, Q67Y, Q67C, I68M, I68Q, I68L, Y69F and Y69H mutations in the R67 
DHFR gene by the PCR based protocol outlined in the Quickchange kit from Stratagene.  
The PCR based reactions, used in site directed mutagenesis, required two complementary 
oligonucleotide primers containing the desired mutation.  The coding strand sequences 
for each nucleotide primer are as follows:  
 (S65A) 5’-GGCTCACCCGGGC(GCA)GTACAGATCTATCC-3’ 
(Q67Y) 5’-CCGGGCTCAGTA(TAT)ATCTATCCTGTTGCGGC-3’,  
 35
(Q67C) 5’-CCGGGCTCAGTA(TGC)ATCTATCCTGTTGCGGC-3’, 
(I68L) 5’-GGGCTCAGTACAG(TTG)TATCCTGTTGCGGCG-3’,  
(I68M) 5’-GGGCTCAGTACAG(ATG)TATCCTGTTGCGGCG-3’,  
(I68Q) 5’-CCCGGGCTCAGTACAG(CAG)TATCCTGTTGCGGCG-3’, 
(Y69F) 5’-GGGCTCAGTACAGATC(TTC)CCTGTTGCGGCG-3’,   
(Y69H) 5’-GGGCTCAGTACAAATC(CAT)CCTGTTGCGGCG-3’. 
  
Concurrent removal of a Bgl II site allowed utilization of Bgl II restriction digests 
to screen for candidate mutant genes (except for the S65A mutant).  To verify the 
presence of the mutation and to determine that no extraneous mutations occurred in the 
R67 DHFR gene, the DNA was sequenced using an ABI PRISM Dye Terminator Cycle 
Sequencing Ready Reaction kit from Perkin Elmer (University of Tennessee Sequencing 
Facility).  
E. coli cells (strain SK383) containing the mutant genes were grown in a modified 
version of TB medium (Tartof et al., 1987).  Cells were grown to the late stationary phase 
in the presence of 200 µg/ml of ampicillin plus 20 µg/ml of TMP.  Cells were lysed using 
an alkaline lysis method (except for the Q67C variant) and protein purification used 
Sephadex G-75, DEAE-Fractogel and DEAE-Sephacyl chromatography steps as 
previously described (Reece et al ., 1991).  A final purification step used either a Mono-Q 
or a HiQ anion exchange column on a Pharmacia FPLC system.  Sonication was used to 
lyse E. coli cells containing the Q67C mutant gene.  Each protein was purified to 
homogeneity as determined by SDS-PAGE. 
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Steady State Kinetics  
 Steady state kinetic data were obtained using a Perkin-Elmer λ3a 
spectrophotometer interfaced with an IBM PS2 according to Howell et al. (1987).  The 
computer program UVSL3 (Softways, Moreno Valley, CA) was used to collect and 
analyze data.  Assays were performed at 30°C in a polybuffer containing 50 mM MES, 
100 mM Tris and 50 mM acetic acid at pH 7 (MTA buffer) (Ellis et al., 1982).  This 
polybuffer maintains a constant ionic strength from pH 4.5-9.5.  Assays were performed 
by the addition of substrate (DHF) and cofactor (NADPH) followed by the addition of 
enzyme to initiate the reaction.  To obtain kcat and Km values for each mutant, the 
concentration of NADPH was held constant at a subsaturating level while the 
concentration of DHF was varied.  This process was repeated using four additional 
subsaturating concentrations of NADPH.  The data were fit globally to the Michaelis 
Menten equation describing a bisubstrate reaction using a nonlinear subroutine of SAS 
(Smiley et al., in press). 
Protein and ligand concentrations were determined spectrophotometrically.  For 
all mutants, extinction coefficients were determined using the biuret assay (Gornall et al., 
1949).  Ligand concentrations were determined using the following extinction 
coefficients: 28,000 M-1cm-1 at 282 nm for DHF (Blakley et al., 1960), 6220 M-1cm-1 at 
340 nm for NADPH (Horecker et al., 1948).  The molar extinction coefficient used to 





Isothermal Titration Calorimetry 
 Binding affinities and the enthalpy associated with binding were monitored using 
isothermal titration calorimetry (ITC) as previously described (Bradrick et al., 1996).  
Briefly, measurements were carried out on a Microcal Omega Ultrasensitive Isothermal 
Titration Calorimeter equipped with a nanovoltmeter for improved sensitivity and 
connected to a circulating water bath for temperature control.  The data were 
automatically collected by an IBM PC running DSCITC data acquisition software and 
were analyzed using Origin software provided by the manufacturer.  The design and 
operation of this instrument have been described by Wiseman et al. (1989).  Samples 
typically consisted of ~90-100 µM tetramer in MTA buffer, pH 8.  Measurements were 
performed at 28oC.  Addition of ligand to buffer only was performed to allow baseline 
corrections. Data were fit to an interacting sites model where the stoichiometry of ligand 
binding was set equal to two. 
 
Gel Filtration Studies  
 Gel filtration studies, at pHs 5 and 8, were carried out at 4° C on a Pharmacia 
FPLC using a Superose 12 (HR 10-30) column with a flow rate of 1.0 ml/min.  The 
column was equilibrated in MTA buffer.  Standard curves at pH 5 and 8 were produced 
by plotting the log molecular weight of protein standards (Pharmacia calibration kit) 
versus Kav.  This allowed determination of the molecular weight and thus the oligomeric 
state of each R67 DHFR mutant.  The Kav is defined as: 
 
    Kav = (VE - VV)/(VB - VV)    (1) 
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where VE is the elution volume, VV is the void volume, and VB is the bed volume of the 
column matrix. 
       
pH Titration of Tryptophan Fluorescence  
 To monitor a pH-dependent equilibrium between tetramer and two protonated 
dimers in wild type or mutant R67 DHFRs, given by the following equation,  
 
     Koverall 
           T + 2nH+     ⇄     2DHn    (2) 
 
tryptophan fluorescence was monitored as a function of pH on a Perkin Elmer LS-5B 
luminescence spectrometer (Nichols et al., 1993).  The emission spectra for the DHFRs 
(excitation at 295 nm) were measured from 300 to 450 nm at each pH during the 
titrations.  The intensity averaged emission wavelength, <λ>, for each emission spectrum 
was calculated using the equation: 
 
    <λ> = Σ(Iiλi)/Σ(Ii)      (3) 
 
where I is intensity and λ is the wavelength (Royer et al., 1993).  <λ> is an integral 
measurement that is less sensitive to noise.  Data were fit to the following equation 
describing the linkage between the tetramer and protonated dimer equilibrium (Nichols et 
al., 1993):  
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Fluobs = {( Fludi - Flutet) {[H]2n/(4KoverallPtot)} {-1 + [1 + 8    
 KoverallPtot/[H]2n)]1/2}} + Fludi     (4) 
 
where Koverall = ([tetramer][H]2n)/dimer * H2n2] in units of M, M2 or M3 for n = 1, 1.5 or 2 
respectively; Fluobs is the observed fluorescence ; Fludi and Flutet are the calculated limits 
for dimer and tetramer fluorescence at low and high pH values; and Ptot is the total 
protein concentration in terms of dimer (Nichols et al., 1993).  The program SAS 
(statistical analysis software) was employed to fit the data using nonlinear regression.  To 
facilitate comparison, the data were normalized by fitting to Fapp = (Yobs - YpH 8)/(YpH 5 - 
YpH  8), where Fapp is a fractional value between 0 and 1 and Yobs, YpH  8, and YpH  5 are the 
optical values associated with the observed pH and the pH limits of 8 and 5, respectively. 
 
Circular Dichroism   
Circular dichroism spectra of mutant and wt R67 DHFRs in 10 mM KH2PO4 at 
pH 5.0 and 8.0 were obtained at 22°C using an Aviv 202 circular dichroism spectrometer.  
The cell pathlength was 1 cm.  Ten spectra were acquired per sample using 1 nm steps 
and 2 s integrations and an averaged spectrum was calculated.  An essentially flat buffer 
baseline scan was then subtracted from the average protein scan.  The CD data are 






The S65A, Q67Y, Q67C, I68M, I68Q, I68L, Y69F and Y69H mutant genes were 
constructed and sequenced as described above.  To evaluate which mutations were most 
functional, E. coli cells were transformed with plasmid DNA containing the mutant genes 
and screened for the ability to confer resistance to trimethoprim. All mutant genes except 
the Q67Y construct provided resistance to the antibiotic at 20 µg/ml.  Only the Q67H, 
I68Q and Y69H mutant genes could not confer TMP resistance at concentrations ≥ 50 
µg/ml TMP. 
The correct molecular mass for the Q67C, I68L, I68M and Y69F mutants was 
confirmed by electrospray ionization mass spectrometry (ESI-MS) on a Thermo Finnigan 
LCQ-DECA ion trap.  The correct mutation site was confirmed for each of these mutants 
by digestion with the endoproteinase GluC.  The resultant peptide mixtures were desalted 
with a C18 ZipTip and directly infused into the ion trap mass spectrometer.  The peptide 
containing the suspected mutation site was isolated and MS/MS was performed to obtain 
sequence information.  To ensure the Q67C mutant did not form a disulfide bond with a 
symmetry related cysteine residue, an exact mass of the intact protein was obtained by 
ESI-MS on an Ion Spec fourier transform-ion cyclotron resonance mass spectrometer.  
This data and a novel technique for detecting mutation sites in the intact protein are 
described in detail in a separate report (Verberkmoes et al., 2002).    The Q67C mutant 
had a measured mass of 8405.15 daltons (monomer), consistent with all the cysteines 
being reduced.   
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Steady State Kinetic Analysis   
Steady state kinetic data are given in Table 1 for mutant and wt R67 DHFRs.  All 
kinetic data were obtained at pH 7 with the exception of Q67H R67 DHFR.  This mutant 
was constructed and characterized at pH 8 as previously described (Park et al., 1997).  
The kinetic values for the S65A mutant are comparable to wt R67 DHFR.  In contrast, the 
Q67H mutation binding to DHF and NADPH by 36 and 110 fold, respectively.  The 
Q67C mutation weakens binding to both DHF and NADPH by approximately 9 fold.  
The I68L and I68M mutations have similar effects, weakening binding to DHF and 
NADPH by approximately 4 and 7-9 fold respectively.  The Y69F mutation weakens 
binding to DHF and NADPH by 8 and 20 fold, while the Y69H mutation weakens 
binding to DHF and NADPH by approximately 8 and 60 fold respectively. 
The changes in both NADPH and DHF Km values suggest the Q67, I68 and Y69 
residues play a dual role and contribute to binding of both ligands.  Furthermore, since 
the ratio of (Km (DHF ) for mutant) / (Km (DHF)  for wt) as well as (Km (NADPH)  for mutant) /  
(Km (NADPH)  for wt) are mostly similar, these residues display very little specificity for 
DHF versus NADPH binding.   For example, in the context of 36-110 fold tighter binding 
of ligands in the Q67H R67 DHFR, there is only a 3 fold preference for NADPH binding.  
Also for the Y69F R67 DHFR, in the context of 7.6-22 fold weaker binding, there is only 
a 3 fold preference for DHF binding.  The largest preference observed is a 7.5 fold 
preference for substrate binding over NADPH, which occurs in the Y69H mutant.  
Effects on kcat are variable and depend on the residue and the particular 
substitution.   No significant effects are observed for the S65A mutant while for the Q67 
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Table 1.  A comparison of steady state kinetic values for R67 DHFR variants at pH 7.0.  
 
DHFR Species (pH 7) 
 
 
kcat    (s-1) 
 






Km (DHF) mutant 
÷ Km (DHF) wt 
 
Km (NADPH) mutant 
÷ Km (NADPH) wt 
Wt R67 DHFRa 1.3 ± 0.07 5.8 ± 0.02 3.0 ± 0.06 - - 
S65A R67 DHFR 1.1 ± 0.10 4.0 ± 0.51 2.9 ± 0.57 0.69 0.97 
Q67H R67 DHFR (pH 8)b 0.022 ±  0.003 0.16 ± 0.01 0.028 ± 0.001 0.027 0.009 
Q67C R67 DHFR 0.10 ± 0.016 55 ± 10 26 ± 4.0 9.5 8.7 
I68L R67 DHFR 0.32 ± 0.06 24 ± 3.0 26 ± 4.0 4.2 8.7 
I68M R67 DHFR 0.17 ± 0.03 25 ± 3.0 21 ± 3.0 4.3 7.0 
Y69F R67 DHFR 2.5 ± 0.04 44 ± 2.1 66 ± 2.6 7.6 22 
Y69H R67 DHFR 0.014 ± 0.002 46 ± 4.5 176 ± 6.0 7.9 59 
a  Values from Reece et al., 1991 
b  Values from Park et al., 199
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mutants, a loss in activity is observed.  Since substantial substrate and cofactor inhibition 
is observed for the Q67H mutant, its kcat value is given at pH 8 and is derived by global 
fitting of kinetic data by FITSIM (Park et al., 1997).  For wt DHFR, kcat at pH 8 is 8.8 
min-1, indicating a 6.8 fold decrease in activity is associated with the Q67H mutation.  
For the Q67C mutant, a 13 fold decrease in kcat is observed when compared to wt R67 
DHFR at pH 7.  A Q67Y mutant was also constructed, however protein production levels 
were low, and the gene did not confer TMP resistance upon host E. coli, implying 
diminished catalytic efficiency.  For the I68 mutants, the I68M substitution has a slightly 
larger effect on kcat with an 8 fold decrease, while the I68L mutant only shows a 4.2 fold 
decrease.  An I68Q mutant was constructed, but the ability of the gene to confer TMP 
resistance was low and an initial protein purification gave low yields with marginal 
activity, suggesting less conservative substitutions decrease catalytic activity more 
dramatically.  For Y69 substitutions, the Y69F mutant was conservative and resulted in a 
2 fold enhancement of kcat.  However the Y69H mutation decreased kcat approximately 90 
fold.  These results indicate the binding surface contributed by residues 67-69 is involved 
in stabilization of the transition state.   
A low level of substrate inhibition was observed for the I68L mutant and a more 
noticeable level was associated with the I68M mutant.  These observations indicate that 
the ternary complex may be slightly different in these mutants and/or the degree of 





Isothermal Titration Calorimetry   
To determine the effect of selected mutations on ligand binding and cooperativity, 
isothermal titration calorimetry was employed to monitor NADPH binding.  Best fits of 
wt R67 DHFR data indicate it binds 2 NADPH molecules, with negative cooperativity 
(Bradrick et. al.,1996).  Figure 2 shows a representative ITC titration between I68L R67 
DHFR and NADPH.  Best fits of the data for all the mutants, which yield Kd values as 
well as the ∆H associated with binding of NADPH, are given in Table 2.  All the mutants 
display negative cooperativity between 2 bound NADPH molecules.  Except for Q67H 
the heat associated with the first peak in panel A was not included in panel B or in the data 
analysis.  R67 DHFR, all mutants display weaker affinity for NADPH in comparison to 
the wt values.  And finally, the difference in affinity between the 2 bound NADPH 
molecules remains relatively the same (from a 38 fold difference between wt sites to a 23 
fold difference between Q67H and I68L sites).  This latter observation indicates the 
cooperativity between two bound NADPH molecules is not affected much by the 
mutations.   
 
Gel Filtration   
To eliminate the possibility that the above changes in catalytic efficiency might be due to 
alterations in the oligomeric state of the mutant R67 DHFRs, their elution patterns at pH 
5 and pH 8 were analyzed using molecular sieving chromatography.  Values 
corresponding to the estimated molecular weight of mutant and wt R67 DHFRs are 





















Figure 2.  An ITC titration involving NADPH binding to I68L R67 DHFR.  Panel A shows 
the series of peaks generated from the heat liberated upon NADPH binding.  As the protein 
approaches saturation, less of each subsequent addition is bound, so the peaks decrease in 
height.  The protein concentration was 87µM tetramer.  Panel B shows the heat liberated per 
mol of titrant added vs. the cofactor/protein tetramer molar ratio. The smooth line shows the 
fit to the data for a model which describes ligand binding to two interacting sites exhibiting 
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Table 2.  A comparison of Kd values describing binding of NADPH to R67 DHFR 
variants at pH 8.0 monitored by ITC. The ITC fit reports microscopic constants (k1 and 
k2), however the Kd values below are the macroscopic constants (K1 and K2).  The 
statistical relationship between microscopic and macroscopic constants is Kd1 = ½ kd1 and 
Kd2 = 2 kd2 (Cantor and Schimmel., 1980).  Values reported for all mutants are fit to an 


















Wt R67 DHFRa 2.5 ± 0.15  
95 ± 4 
38 -8.6 ± 0.02 
-5.8 ± 2.5 
2 
S65A R67 DHFR  3.0 ± 0.05 
89 ± 1.6 
30 -9.1 ± 0.06 
-7.9 ± 0.42 
2 
Q67H R67 DHFRb 0.027 ± 0.008 
0.62 ± 0.11 
23 -4.8 ± 0.10 
-2.5 ± 0.40 
2 
I68L R67 DHFR 23 ± 2.1 
520 ± 54 
23 -5.6 ± 0.12 
-4.6 ± 0.35 
2 
Y69F R67 DHFR 16 ± 1.1 
490 ± 36 
31 -2.6 ± 0.05 
-4.7 ± 0.09 
2 
a  From Bradrick et al., 1996 




















Wt R67 DHFR 40,000 ± 990 26,000 ± 920 
S65A R67 DHFR 40,000 ± 600 26,000 ± 300 
Q67C R67 DHFR 41,000 ± 110 29,000 ± 230 
I68L R67 DHFR 43,000 ± 980 29,000 ± 930 
I68M R67 DHFR 42,000 ± 160 27,000 ± 950 
Y69F R67 DHFR 43,000 ± 990 26,000 ± 920 





as a dimer and at pH 8.0, it elutes as a tetramer.  The mutant proteins have similar 
estimated molecular weights as wt R67 DHFR at pH 5.0 and 8.0.  The amino acid 
sequence predicts molecular weights of 16,860 and 33,720 for dimeric and tetrameric 
R67 DHFR (Nichols et al., 1993).  Aberrant molecular weight estimates determined by 
gel filtration are not unusual as the hydrodynamic volume or shape of the molecule as 
well as the size affects elution (Potschka et al., 1987). 
 
pH Titration of Tryptophan Fluorescence   
To examine any subtle effects the mutations may have had on the tetramer to two 
dimers equilibrium, steady state tryptophan fluorescence was monitored as a function of 
pH.  Symmetry related H62, H162, H262 and H362 residues located at the dimer 
interfaces are involved in stabilizing tetrameric R67 DHFR.  Titration of these residues 
results in tetramer destabilization and protonated dimer formation.  Since W38 also 
occurs at the dimer-dimer interfaces, tryptophan fluorescence can be used to monitor  
whether the W38 environment is solvent exposed (dimer) or buried in a hydrophobic 
environment (tetramer).  
The pH titration data for mutant and wt R67 DHFRs are listed in Table 4.  The 
Koverall values for each mutant are similar to those for wt R67 DHFR with the best fit 
occurring when n=3, where n corresponds to the number of protons added to the dimer-
dimer interfaces resulting in dissociation.  To aid comparison, the data were converted to 

















Figure 3.    A pH titration of R67 DHFRs monitored by fluorescence.  The intensity 
averaged wavelength, <λ >, for wt and Y69F R67 DHFRs (  and  points respectively) 
was monitored as a function of pH.  The protein concentration of wt and Y69F R67 
DHFRs was 2 µM.  The data were each fit to equation 4 and best fit values are listed in 













Table 4. Best Fit Values for the pH Dependent Dissociation of Tetramer ⇄ 2 Dimers as 
Monitored by Fluorescence. 
 
DHFR Species K overall (= Ka 2n / Kd) 
for n=3 in units of M2 
Wt R67 DHFR 1.2 x 10 –13 ± 4.00 x 10 –14 
S65A R67 DHFR 2.21 x 10 –13 ± 4.14 x 10 -14 
I68L R67 DHFR 5.73 x 10 –14 ± 1.62 x 10 -14 
I68M R67 DHFR 1.04 x 10 –13 ± 7.12 x 10 -14 
Y69F R67 DHFR 4.79 x 10 –13 ± 1.13x 10 –13 








Minimal changes might be expected for the I68 and Y69 mutants as they are not near the 
dimer-dimer interface.  Q67 does however occur at the bottom of the dimer-dimer  
interface, and mutation of this residue could alter the stability of the tetramer.  The Fapp 
plot for Q67H shows that the mutation slightly destabilizes the tetramer (Park et. al., 
1997).  Alteration (or removal) of the Q67–Q367 interactions by the Q67H mutation may 
be the mechanism of destabilization.  In this study, the data for the Q67C mutant visually 
appeared to display a titration (data not shown), however since the overall signal change 
was small and pre- and post-transition slopes were present, the fitting program could not 
obtain a fit with reasonable errors.  Thus quantitation of the Koverall for the Q67C mutant 
was not obtained.  For the other mutants, the Fapp plots clearly show that the mutations 
minimally perturb the tetramer to two dimers equilibrium. 
 
Circular Dichroism  
To evaluate the effect of the mutations in the active site pore on the overall 
secondary and tertiary structure of R67 DHFR, CD spectra were obtained at pHs 5.0 and 
8.0 and are depicted in Figure 4.  For most cases, smaller signals are observed for the 
mutants compared to wt, particularly at pH 5.  The CD data are consistent with the 
protein being folded with minimal alterations of the conformation (i.e. oligomerization 
state) as a function of pH.  The differences in the CD signal may reflect subtle changes in 
the structure and/or different contributions of aromatic groups to the signal due to altered 
















































Figure 4.   Assessment of secondary structure in R67 DHFRs by CD.  Panel A displays 
the scans of various representative DHFRs at pH 8 where the proteins are tetrameric.  Wt 
R67 DHFR is given by a solid line, Q67C R67 DHFR by a dash-dot-dot line, I68L by a 
dashed line and Y69H R67 DHFR by dash-dot line.  Panel B displays the scans at pH 5 
where the proteins are dimers.  Wt R67 DHFR is given by a solid line, Q67C R67 DHFR 
by a dash-dot-dot line, I68L by a dashed line and Y69H R67 DHFR by dash-dot line.  
Data are presented as the mean residue ellipticity, θ, by taking 108 g/mol as the mean 




The S65, Q67, I68 and Y69 Residues Comprise 47% of the Binding Surface   
 Single mutations in the R67 DHFR gene result in four mutations per 
homotetramer.  Since R67 DHFR possesses a single active site pore, the effect of four 
concurrent mutations on the ligand binding surface can be profound.  For example, the 
cumulative effect of four mutations at either K32, W38 or H62 at the dimer-dimer 
interfaces results in destabilization of the tetramer such that only dimers are formed 
(West et al., 2000; Hamilton., 1997; Park et al., 1997).  For the mutations in the  
present study, the S65 residues contribute 5% of the binding surface; Q67 residues, 14 %; 
the I68 residues, 19% and the Y69 residues, 9%.  The total surface area (Connolly) 
contributed by the S65, Q67, I68 and Y69 residues is 47% of the total available 
(generated from residues 32, 36, 46, and 64-69).  Thus large effects on ligand binding 
may be expected for mutations at these residues.  A corollary of four mutations occurring 
simultaneously per active site pore is that mutations most likely need to be conservative 
to not have very profound effects on protein structure and/or function.  For example, the 
Y69F mutant is quite active, while the Y69H mutant is not.  In a second example, the 
I68L and I68M mutants have similar steady state kinetic values and both are less efficient 
than wt R67 DHFR. However, the I68Q mutant gene only conferred resistance to a low 
level of TMP and from an initial purification of the I68Q mutant protein, it was clear that 




How Can the Effect of the Mutations Be Understood?  
 In E. coli chromosomal DHFR, mutations in the DHF binding pocket affect DHF 
Kd values by 1700-0.5 fold, while Kd values for NADPH are concurrently altered 3.33-
0.45 fold (Miller and Benkovic, 1998).  The general trend observed in these mutants is 
that DHF, but not NADPH binding, is affected.  A similar trend is observed for mutations 
in the NADPH binding pocket with up to 23 fold increases for NADPH Kd values, while 
DHF Kd’s are only altered by up to 4 fold.  These results indicate the effects of the 
mutations are mostly local, and focus on the ligand whose contacts are disrupted.  Lesser 
to no effects are observed on binding of the second ligand.   
In contrast to the above effects of mutations in chromosomal DHFR, R67 DHFR 
shows a different pattern.  The D2 symmetry in R67 DHFR dictates that the effect of a 
mutation on a binding site must be paralleled by a similar effect at the symmetry related 
sites.   This is most clearly seen in the ITC data which monitor binding of two NADPH 
molecules.   From an examination of the binding data in Table 2, the mutations at Q67, 
I68 and Y69 clearly alter both NADPH binding events.  For the Q67H mutant, both 
NADPH molecules are bound approximately 100 times more tightly.  In contrast, for the 
I68L mutant, both NADPH molecules are bound approximately 10 times more weakly.  
While the effects of the various mutations on the Kd values range over three orders of 
magnitude, the difference in affinity between the bound NADPH pairs is barely altered.  
A ratio of Kd2 (for the second NADPH) to Kd1 (for the first NADPH) ranges from a 23 
fold (Q67H and I68L) to a 38 fold difference (wt).  This small an effect on the Kd2/Kd1 
ratio suggests the mutations influence the affinity for NADPH at both symmetry related 
sites to an equal extent.  
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The ratio of Kd2 to Kd1 for pairs of bound NADPH molecules may also be 
considered a measure of the cooperativity between bound NADPH molecules.  This 
alternative, linked point of view states that when binding of one ligand is altered, binding 
of the second ligand may also be changed depending on the extent of interaction between 
ligands.  Thus these studies also address the relationship between ligand cooperativity 
and symmetry effects in R67 DHFR. 
The effects of symmetry and inter-ligand cooperativity can be unrelated if the 
binding sites are separate. For this simple situation, a mutation should alter both Kd 
values equally.  However if the ligands interact when bound, then symmetry effects and 
ligand cooperativity are expected to show some degree of linkage.  This is especially true 
if the ligands bind near the center of the active site pore near the 222 symmetry operator.  
For the case of negatively interacting sites, typified by NADPH binding, the first 
NADPH is proposed to bind and cross the center of symmetry in R67 DHFR (Bradrick et 
al., 1996).  This results in loss of a symmetry related site and a weakened affinity for the 
second NADPH molecule.  The effects of mutations on this model rely on steric 
hindrance, so if the position of the NADPH bound first is not drastically altered by the 
mutation, minimal effects on NADPH cooperativity may be expected.  If the position of 
the NADPH bound first is greatly altered, the position of the NADPH bound second 
could also be altered, and this difference reflected by a larger change in Kd.  That the 
cooperativity between bound NADPH molecules changes minimally in our series of 
mutants suggests the relative position of the bound NADPH pairs must not be too 
drastically altered with respect to each other.   
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The extent of linkage between symmetry and cooperativity between NADPH and 
DHF can be broached by considering the steady state kinetic data.  When binding is 
assessed using the kinetic data in Table 1, the Q67, I68 and Y69 mutations can be seen to 
alter Km values for both NADPH and DHF.  The Y69F mutant displays 8 fold weaker 
binding to DHF and 22 fold weaker binding to NADPH than wt.  In contrast, when 
compared to wt values, the Q67H mutant displays 36 and 110 fold tighter binding to 
DHF and NADPH, respectively.  In the context of these changes in Km, which vary up to 
three orders of magnitude, the ability of the mutations to preferentially alter NADPH vs. 
DHF binding appears marginal.  For example, the Q67H mutant enhances NADPH 
binding (compared to DHF) by only three fold, while the Y69F mutant weakens NADPH 
binding (compared to DHF) by three fold.  The I68L and I68M mutants all have an 
approximately two fold preference for DHF binding, while the Y69H mutant has a seven 
fold preference for DHF binding.   Again, while changes are observed, the differential 
effect they have on binding one ligand versus the other are orders of magnitude less.   
However in contrast to the ITC data, which essentially showed no change in the 
cooperativity between 2 bound NADPH molecules, the kinetic data hint at some minimal 
alterations in cooperativity between NADPH and DHF.    
The issue of whether the mutations exert their effect by affecting both the 
NADPH and DHF binding sites or by affecting the cooperativity between ligands may be 
a moot point if cooperativity is an important component in catalysis for this enzyme.  
Consider a multi-point attachment model to describe ligand binding (Sapse et al., 1992).  
In this model, at least three points are required to bind the ligand with sufficient 
uniqueness for a reaction to display stereospecificity.   A two point attachment would 
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allow rotation and result in racemic product mixtures.  If numerous attachment points in 
R67 DHFR involve NADPH•DHF interactions, then cooperativity is an essential part of 
the mechanism.  The resulting transition state in R67 DHFR requires some degree of 
interaction between the pteridine ring of DHF and the nicotinamide ring of NADPH.  
This view would be more consistent with an endo conformer of the transition state (where 
the nicotinamide ring overlaps the more bulky side of the pteridine ring) as compared to 
an exo conformer (with minimal overlap of the pteridine and nicotinamide rings; Andres 
et al., 1996; March et al., 1992).  The endo transition state for DHFR has been evaluated 
as 2-8 kcal/mol more stable than the exo transition state due to the inter-ring interactions 
(Castillo et al., 1999).  The exo model describes the transition state associated with 
chromosomal E. coli DHFR as this active site constellation constrains how ligands bind 
and funnels the transition state towards the exo conformer.  In contrast to chromosomal 
DHFR, the results obtained in these mutagenesis studies are consistent with an endo 
model for the transition state in R67 DHFR.  Interligand NOE NMR data also favor this 
model (Li et al., 2001) as do docking studies focused on generating a ternary complex 
model by Howell et al. (2001). 
 
How Unique Are the NADPH and DHF Binding Sites?  
 Using computer docking algorithms, a model of the R67 DHFR•NMN•Fol1 
ternary complex has been proposed (Howell et al., 2001).  Using a symmetry operation to 
overlap the two proposed binding sites indicates that the nicotinamide ring of NADPH 
occupies a very similar position to that of the N5,N8 containing ring of the pteridine ring 
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of folate.  This partial overlap of sites also predicts that the mutations will have effects on 
binding both DHF and NADPH.   
 
Enthalpy - Entropy Compensation?   
Binding of NADPH produces exothermic ITC isotherms for all the mutants.  
From the Kd values given in Table 2, values for ∆G can be calculated using the 
relationship ∆G= -RT ln Ka where Ka is the association constant and equals 1/Kd.  From 
this, T∆S can be calculated from ∆G=∆H-T∆S.  A plot of ∆H vs. T∆S is reasonably 
linear as shown in Figure 5, while a plot of ∆H vs. ∆G shows no trends (Figure 5B).  
Additional data points describing binding of DHF, folate, CB3717 (a folate analog) and 
NADP+ in various binary and ternary complexes are also shown for wt and Q67H R67 
DHFRs (Bradrick et al., 1996; Park et al ., 1997).  These additional points strengthen the 
linear correlation between ∆H and T∆S as well as extend the observable range. 
Alteration of the ligand or the enzyme can be expected to result in different 
degrees of hydrogen bonding and van der Waals contacts which in turn can alter the 
degrees of freedom of the ligand and amino acid side chain (Gilli et al., 1994; Dunitz et 
al., 1995).  The former would affect ∆H, the latter, T∆S.  Solvent re-organization may be 
involved in the effects of different ligands and mutant enzymes on ∆H and T∆S 
(Chervenak et al., 1994; Grunwald et al., 1995).  Finally any proton exchange between 
enzyme and buffer to which ligand binding may be coupled could also be perturbed by 










































Figure 5.  Thermodynamic analysis of binding.  Panel A shows a plot of T∆S versus ∆H 
for various mutant R67 DHFRs and various ligands.  Values for NADPH binding to the 
mutants described in this study are given by n points.  Values for binding of various 
ligands to wt R67 DHFR ( ) are taken from Bradrick et al., (1996) while values for 
binding of various ligands to Q67H R67 DHFR ( ) come from  Park et al., (1997).  23 
different data points are given.  The slope of the line is 0.90 and the correlation 
coefficient is 0.82.  These data indicate a strong linear correlation between ∆H and T∆S. 






thermodynamics of ligand binding.  With these caveats in mind, one observation from 
Figure 5 is that most of the wt interactions (  points) are enthalpically driven, while most  
of the mutant interactions (n and  points) possess both enthalpic and entropic 
contributions.  In addition, the most negative ∆H values arise during binding of two 
ligands per active site pore in the wt enzyme (R67 DHFR•DHF•NADP+, R67 
DHFR•2folate and R67 DHFR•2 CB3717), providing some support to the notion that 
ligand-ligand interactions may be important to binding and ultimately, catalysis.   
 
What are the Roles of the S65, Q67, I68 and Y69 Residues?  
 From the steady state kinetic analyses, it is clear that the Q67, I68 and Y69 
mutations affect both Km and kcat values.  The S65 mutant did not alter kinetic or ITC 
values significantly, indicating it doesn’t interact directly with ligands.  Alternatively, 
from the docking results using SLIDE, S65 may interact indirectly with ligands through 
an intermediary water molecule and perhaps the S65A substitution is not sufficient to 
perturb the water structure. 
There are several patterns observed for mutations at Q67, I68 or Y69.  The most benign 
mutation is Y69F, as kcat is slightly enhanced while kcat/Km is decreased.  This result 
indicates that Y69F destabilizes both the ground and the transition states, although the 
former more than the latter (Fersht A.R, 1999).  This behavior minimally corresponds to 
a “uniform binding effect” and may indicate a slight “enhancement of an elementary 
step” (Albery and Knowles., 1976).  All the other mutations (except Q67H) show 
decreased kcat values and even greater decreases in kcat/Km values.  These results indicate 
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destabilization of the ES complex and even greater destabilization of the transition state.   
This would correspond to a “differential binding effect” (Albery and Knowles, 1976).  
The last mutational pattern occurs with the Q67H mutant.  Tighter binding to NADPH 
and DHF is observed as well as a decreased kcat value (Park et al., 1997).  While tighter 
binding of NADPH and DHF in the Q67H mutant may imply 
ligand binding in wt R67 DHFR involves some degree of ground state destabilization, the 
concurrent tighter binding of ligand at the symmetry related sites, results in substantial 
cofactor and substrate inhibition.    
  
Is R67 DHFR A Primitive Enzyme?  
 Our results indicate R67 DHFR provides a very different active site constellation 
than chromosomal DHFR or most other enzymes.  The 222 symmetry of the structure, 
combined with the single active site pore, generates an unusual approach to catalysis.  
One consequence of this symmetry is that the presence of four symmetry related 
mutations can profoundly affect catalysis.  Therefore it is difficult for this enzyme to 
acquire mutations that facilitate catalysis and evolve to a high efficiency.  Also linked to 
the symmetry is the proposal that inter-ligand cooperativity may be quite important in 
binding.  The ability of the ligands to interact may somewhat mitigate the necessity of the 
ligands to bind to unique sites in the enzyme.  Instead, the enzyme appears to possess a 
binding “hot spot” that can accommodate (with some degree of overlap) both folate and 
NADPH.  Finally the above data are consistent with the notion that R67 DHFR utilizes an 
endo conformer of the transition state, involving cooperativity between ligands during 
 62
binding.  All these observations suggest R67 DHFR is a good model for a primitive 
enzyme.   
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The Role of Cooperativity and Interligand Interactions in the Catalytic Function of 














 R67 dihydrofolate reductase (DHFR) is a novel protein that provides clinical 
resistance to the antibacterial drug trimethoprim and it shares no sequence or structural 
homology with chromosomal DHFRs.  Recently a high resolution crystal structure of 
R67 DHFR has been solved.  From this structure, R67 DHFR is a homotetramer that 
possesses exact 222 symmetry and a single active site pore that traverses the length of the 
protein (Narayana et al., 1995).  Although this symmetry implies that four symmetry 
related binding sites must exist for each substrate as well as each cofactor, isothermal 
titration calorimetry studies indicate only two molecules bind. Three possible 
combinations of bound ligands have been observed.  These include two dihydrofolate 
molecules or two NADPH molecules or one substrate + one cofactor (Bradrick et al., 
1996).  The latter is the productive ternary complex.  To evaluate the roles of A36, Y46, 
T51, G64 and V66 residues in the active site pore, site directed mutagenesis was 
performed.  One mutation in the gene creates four mutations per active site pore, which 
typically result in large cumulative effects.  Out of these, only the Y46 and V66 mutant 
genes conferred trimethoprim resistance upon host E.coli.  The resulting mutant proteins 
displayed steady state kinetic behavior similar to wild type R67 DHFR.  Isothermal 
titration data were utilized to analyze the role interligand cooperativity may play in the 
catalytic function of R67 DHFR.  These results support a model where R67 DHFR 
utilizes an unusual “hot spot” binding surface capable of binding both ligands and 
facilitates catalysis simply by binding ligands in the appropriate orientation to stabilize 
the transition state.  Thus R67 DHFR has adopted a novel yet simple strategy to reach the 
transition state compared with other more highly evolved DHFRs. 
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Introduction 
Dihydrofolate reductase (DHFR) catalyzes the NADPH dependent reduction of 
7,8-dihydrofolate to 5,6,7,8-tetrahydrofolate.  This reaction plays a crucial role in folate 
metabolism because tetrahydrofolate plays a vital role as a one-carbon donor in the 
synthesis of thymidylate, purine nucleosides and other metabolic intermediates.  
Inhibition of this enzyme, therefore, results in effective blockage of DNA synthesis and 
leads to cell death. 
 Trimethoprim is an active site inhibitor of bacterial DHFRs and is commonly 
administered to treat numerous bacterial infections (Aymes et al., 1992).  Resistance to 
trimethoprim (TMP) has been clinically determined to be correlated with the production 
of R-plasmid encoded DHFRs.  Type II R-plasmid encoded R67 DHFR is of particular 
interest because it is genetically and structurally unrelated to chromosomal DHFRs.  
These unique distinctions, therefore, indicate that differences in catalytic strategies 
between the R-plasmid encoded enzyme and chromosomal DHFR exist. 
Although originally crystallized as a dimer, the active homotetrameric structure of 
R67 DHFR has recently been crystallized both as an apoenzyme and as a binary complex 
with folate (Narayana et al., 1995).  The 78 amino acid monomer possesses a five 
stranded β barrel fold that spontaneously associates with three equivalent monomers to 
form a toroidal shaped homotetramer with a pore transversing the length of the protein.  
This pore has been described as the active site by difference Fourier maps describing 
bound folate. Unlike most oligomeric proteins, which possess one active site per 
monomer, R67 DHFR possesses a single active site pore, which is unusual. Few 
examples of an oligomer with only one active site have been cited.  Among these include 
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the AIDS protease (Wlodawer et al., 1989) and the bis-phosphoglycerate binding site 
located in the central pore of hemoglobin (Arnone., 1972).      
A 222 symmetry operator occurs at the center of the active site pore.  This unique 
symmetry dictates that for each binding site, there must be three symmetry related sites 
generated by 180o rotations along the x, y and z axes.  However, binding studies using 
isothermal titration calorimetry (ITC) indicate that only two molecules bind concurrently, 
most likely due to steric constraints.  Three possible combinations of bound ligands have 
been observed.  These include two substrates (DHF or folate), two cofactors (NADPH), 
or one substrate and one cofactor (Bradrick et al., 1996).  The latter is the productive 
ternary complex, while the first two are nonproductive complexes which block access to 
the active site pore.  These data indicate that each half pore can accommodate either DHF 
or NADPH.  
Although a random addition mechanism for bound ligands might be expected, the 
positive and negative cooperativity patterns associated with DHF and NADPH binding 
respectively serve to establish a productive catalytic channel where free enzyme binds 
cofactor first, followed by substrate to form the productive ternary complex.  It should be 
noted that ligand induced protein conformational changes most likely do not occur as no 
strong difference in electron density is observed upon comparing the apoenzyme crystal 
structure with the binary folate-R67 DHFR complex.  The observed cooperativity 
patterns are therefore due to interactions between ligands. 
Difficulties arising from the unusual 222 symmetry have prevented solving crystal 
structures of a productive ternary complex.  Computational, kinetic and NMR studies, 
however, have suggested a model of a productive ternary complex where R67 DHFR 
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utilizes a novel yet simple strategy to catalysis  (Howell et al., 2001; Strader et al., 2001; 
Li et al., 2001).  The computational studies by Howell et al., (2001) suggest the active 
site pore to be an unusual "hotspot" binding surface in which several residues along the 
pore surface (and their symmetry related partners) are involved in binding both substrate 
and cofactor.  Among these are the residues Q67 and I68 located nearest to the center of 
symmetry and Y69, which is located further out.  Steady state kinetic analysis indicates 
that mutations at these positions result in elevated Km values for both cofactor and 
substrate and that these residues display very little, if any, specificity for NADPH versus 
DHF, consistent with a dual role in binding (Strader et al., 2001).  
The residues that establish the active site pore of R67 DHFR can be delineated in 
three ways.  The first involves utilizing information from the folate co-crystal structure 
(Narayana et al., 1996).  This is limited to residues S65, V66, Q67, I68 and Y69 as the 
density for only the pteridine rings of folate is observed.  The second approach involves 
computational docking and implicates more residues (Table 1).  The third approach 
involves identifying residues and atoms exposed in internal cavities of protein structures.  
This avenue utilizes the algorithm CAST (Moult et al., 1999).  Table II indicates the 
residues that create the surface.  Since R67 DHFR is a homotetramer, only residues from 
one monomer are listed.  Out of the above residues, we have previously examined the 
roles of S65, Q67, I68 and Y69 (Strader et al., 2001).  This chapter serves to examine the 
roles of other residues in the active site pore.  The residues involved in this study include 















Figure 1. Wire-frame model of tetrameric R67 DHFR taken from the structure of 
Narayana, N., Matthews, D.A., Howell, E.E., and Xuong, N.H. (1995) Nat. Struct. Biol. 
2, 1018-1025. This structure is viewed down the center of the central pore. Individual 
chains are displayed in orange (chain A), yellow (chain B), cyan (chain C), and green 
(chain D).  The 222 symmetry dictates that each residue has three symmetry related 
partners that contribute to binding. Individual residues are displayed as CPK surfaces in 









Table 1. List of A) predicted contacts for an NADPH conformer docked into R67 
DHFR•Fol using DOCK.  The nicotinamide ring is syn with respect to its ribose; 
hydrogens are not shown  (Howell et al., 2001).  Residues and predicted contacts 
involved in this study are boldfaced. 
 
 
NADPH atom                Monomer, residue and atom   Distance in Ångstroms 
Adenine: AN7                                   A: T51: OG1 3.47 
Nicotinamide ribose: NC5’               A: Q67: CG 3.60 
Nicotinamide: O7                              A: Q67 : CG 3.49 
Nicotinamide: O7                              A: Q67: OE1 3.09 
Nicotinamide ribose: NC2’               A: Q67: NE2 3.15 
Nicotinamide ribose: NO2’               A: Q67: NE2 3.43 
Nicotinamide ribose: NO5’               A: I68: O 2.99 
PPi: O3                                               A: I68: O 3.08 
PPi: P2                                               A: I68: O 3.48 
Nicotinamide ribose: NC5’               A: I68: O 3.43 
PPi: AO1                                            A: Y69: CD1 2.86 
PPi: AO2                                            A: Y69: CD1 3.14 
PPi: P1                                               A: Y69: CD1 3.29 
PPi: AO1                                            A: Y69: CD1 3.59 
PPi: AO2                                            A: Y69: CE1 2.88 
Adenine: AN6                                   B: G64: O 3.01 
Adenine: AC6                                    B: G64: O 3.18 
Adenine: AN1                                   B: G64: O 3.33 
Nicotinamide: NC5                           C: V66: O 3.16 
Nicotinamide: NC5                           C: V66: O 3.17 
Nicotinamide: N7                              C: Q67: CG 3.47 
Nicotinamide: NC4                           C: Q67: CD 3.41 
Nicotinamide: NC3                           C: Q67: CD 3.50 
Nicotinamide: NC4                           C: Q67: CD 3.60 
Nicotinamide: N7                              C: Q67: NE2 3.43 
Nicotinamide: NC7                           C: Q67: NE2 3.47 
Adenine ribose: AO2                         D: K32: CE 3.28 
Adenine ribose: AO1                         D: K32: CE 2.88 
Adenine ribose: P                              D: K32: CE 3.58 
Adenine ribose: AO2                         D: K32: NZ 3.38 
Adenine ribose: AO1                         D: K32: NZ 3.58 
Adenine: AC2                                    D: A36: CB 3.54 
Adenine: AN3                                   D: A36: CB 3.52 
Adenine ribose: AO1                         D: Y69: CD1 3.12 
Adenine ribose: AO1                         D: Y69: CE1 3.20 
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Table  1 continued. B) List of contacts for the top scoring folate conformer docked into 
R67 DHFR•NMN using DOCK. Hydrogens are not explicitly shown (Howell et al., 







Folate atom               Monomer, residue and atom          Distance in Ångstroms 
Pterid ine: N8                         B: Q67: CD               3.24 
Pterid ine: C7 B: Q67: CD 3.46 
Pterid ine: N8  B: Q67: OE1 3.43 
Pterid ine: N8  B: Q67: NE2 3.52 
Pterid ine: C7  B: Q67: NE2 3.33 
Glu: O2                 C: K32: CD               3.28 
Glu: O E2             C: K32: C E 3.06 
Glu: O2             C: K32: C E 3.60 
Glu: O1             C: K32: C E 3.31 
Glu: C             C: K32: C E 3.31 
Glu: O E2             C: K32: N Z 3.58 
Glu: O2             C: K32: N Z 3.52 
Glu: O1             C: K32: N Z 3.20 
Glu: C             C: K32: N Z 3.45 
Glu: C G1             C: K32: N Z 3.59 
Glu: O1             C: A36: CB 2.88 
Glu: O2             C: Y69: C E1 3.13 
Glu: O2             C: Y69: C Z 3.57 
Glu: O2             C: Y69: OH 3.20 
Pterid ine: N5                                 D: V66: O 3.52 
Pterid ine: C4            D: Q67: CG               3.24 
Pterid ine: O4             D: Q67: CG 3.59 
Pterid ine: N3             D: Q67: CG 3.29 
Pterid ine: C8A             D: Q67: CD 3.57 
Pterid ine: C4A             D: Q67: CD 3.57 
Pterid ine: C4A             D: Q67: OE1 3.52 
Pterid ine: O4             D: I68 : N                   3.10 




Table 2. CAST identifies all residues and atoms exposed in the binding cavity (Moult et 
al., 1999). The residues that create the central pore surface of R67 DHFR are listed 
below. Only residues from one monomer are given.  Residues involved in this study are 
boldfaced.  Residues not yet studied are italicized. 
 
 
Atom  Number Side Chain Atom Residue Number 
104 CD Lys A 32 
105 CE Lys A 32 
106 NZ Lys A 32 
111 CB Lys A 33 
116 N Ser A 34 
118 C Ser A 34 
119 O Ser A 34 
121 OG Ser A 34 
123 CA Gly A 35 
126 N Ala A 36 
214 CE2 Tyr A 46 
216 OH Tyr A 46 
228 OG1 Thr  A 48 
242 CB Leu A 50 
245 CD2 Leu A 50 
250 CB Thr A 51 
251 OGI Thr A 51 
346 O Gly A 64 
348 CA Ser A 65 
351 CB Ser A 65 
352 OG Ser A 65 
353 N Val A 66 
356 O Val A 66 
357 CB Val A 66 
359 CG2 Val A 66 
361 CA Gln A 67 
365 CG Gln A 67 
366 CD Gln A 67 
367 OE1 Gln A 67 
368 NE2 Gln A 67 
369 N Ile A 68 
372 O Ile A 68 
374 CGI Ile A 68 
376 CD1 Ile A 68 
378 CA Tyr A 69 
383 CD1 Tyr A 69 
385 CE1 Tyr A 69 
388 OH Tyr A 69 
394 CG Pro A 70 
395 CD Pro A 70 
409 CA Ala A 73 
411 O Ala A 73 
412 CB Ala A 73 
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Structurally, these residues are located away from the symmetry operator.  With the 
exception of Y46, Tables 1a and 1b suggest these residues to be involved in ligand 
binding (Howell et al., 2001).  For example, A36 may be involved in side chain contacts 
with both substrate and cofactor while T51 may interact with the cofactor.  G64 is 
proposed to form a backbone interaction with the cofactor while V66 may form backbone 
interactions with both ligands.  Although these tables represent contacts for the top 
scoring conformers, Y46 is predicted to hydrogen bond with the substrate when 
additional scoring conformers are used.      
To evaluate their role in ligand binding, mutant R67 DHFR genes were 
constructed and the effects assessed.  Another important issue addressed in this chapter is 
the use of isothermal titration calorimetry to assess a potential correlation between 
enthalpy and catalytic efficiency. 
 
Materials and Methods 
 
Construction and Expression of Mutant R67 DHFRs   
A synthetic R67 DHFR gene, carried in pUC8, has been previously described 
(Reece et al., 1991).  Site directed mutagenesis using the appropriate primers was 
employed to construct A36S, Y46F, Y46H, T51A, T51V, G64A, V66A and V66T 
mutations in the R67 DHFR gene by the PCR based protocol outlined in the Quickchange 
kit from Stratagene.  The PCR based reactions, used in site directed mutagenesis, 
required two complementary oligonucleotide primers containing the desired mutation.  
The coding strand sequences for each nucleotide primer are as follows:  
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 (A36S) 5’-CGTAAGAAATCCGGC(TCC)GCCTGGCAAGGTC-3’ 
(Y46F) 5’-CAGATTGTCGGGTGG(TTC)TGCACAAATTTGACCC-3’,  
(Y46H) 5’- CAGATTGTCGGGTGG(CAC)TGCACAAATTTGACCC- 3’, 
(T51A) 5’-GCACAAATTTG(GCC)CCCGAGGGCTACG-3’,  
(T51V) 5’-GCACAAATTTG(GTC)CCCGAGGGCTACG-3’,  
(G64A) 5’-CAGGATAGATCTGTACTGA(CGC)CGGGTGAGCCTCAGAC-3’, 
(V66T) 5’-GCTCACCCGGGCTCA(ACA)CAGATCTATCCTGTTGC-3’,   
            (V66A) 5’- GCTCACCCGGGCTCA(GCA)CAGATCTATCCTGTTGC 
 
Concurrent removal of a NarI site near the A36 position allowed utilization of 
NarI restriction digests to screen for candidate A36S mutant genes.  Knocking out an 
MstII site allowed preliminary screening of T51 mutants.  Concurrent removal of a Bgl II 
site was performed to screen candidate V66 mutants.  After restriction digests, to confirm 
the mutation and to determine that no extraneous mutations occurred in the R67 DHFR 
gene, the DNA was sequenced using an ABI PRISM Dye Terminator Cycle Sequencing 
Ready Reaction kit from Perkin Elmer (University of Tennessee Sequencing Facility).  
E. coli cells (strain SK383) containing the mutant genes were grown in a modified 
version of TB medium (Tartof and Hobbs, 1987).  Cells were grown to the late stationary 
phase in the presence of 200 µg/ml of ampicillin.  20 µg/ml of TMP was added if the 
gene conferred TMP resistance upon host E.coli.  Y46F, V66A and V66T mutant genes 
provided TMP resistance.  Cells were lysed using an alkaline lysis method and protein 
purification used Sephadex G-75, DEAE-Fractogel and DEAE-Sephacyl chromatography 
steps as previously described (Reece et al., 1991).  A final purification step used either a 
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Mono-Q or a HiQ anion exchange column on a Pharmacia FPLC system.  Each protein 
was purified to homogeneity as determined by SDS-PAGE. 
 
Steady State Kinetics  
 Steady state kinetic data were obtained using a Perkin-Elmer λ3a 
spectrophotometer interfaced with an IBM PS2 as previously described by Howell et al. 
(1987).  The computer program, UVSL3 (Softways, Moreno Valley, CA), was used to 
collect and analyze data.  Briefly, assays were performed at 30°C in a polybuffer 
containing 50 mM MES, 100 mM Tris and 50 mM acetic acid at pH 7 (MTA buffer) 
(Ellis and Morrison, 1982).  This polybuffer maintains a constant ionic strength from pH 
4.5-9.5.  Assays were performed by the addition of substrate (DHF) and cofactor 
(NADPH), followed by the addition of enzyme to initiate the reaction.  To obtain kcat and 
Km values for each mutant, the concentration of NADPH was held constant at a 
subsaturating level while the concentration of DHF was varied.  This process was 
repeated using four additional subsaturating concentrations of NADPH.  The data were fit 
to the bisubstrate Michaelis Menten equation utilizing a macro written for SAS™ 
(Smiley et al., in press). 
Protein and ligand concentrations were determined spectrophotometrically.  For 
all mutants, extinction coefficients were determined using the biuret assay (Gornall et al., 
1949).  Ligand concentrations were determined using the following extinction 
coefficients: 28,000 M-1cm-1 at 282 nm for DHF (Blakley et al., 1960) and 6220 M-1cm-1 
at 340 nm for NADPH (Horecker et al., 1948).  The molar extinction coefficient used to 
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assess DHFR reduction of DHF and NADPH was 12,300 M-1cm-1 (Baccanari et al., 
1975). 
 
Isothermal Titration Calorimetry 
 Binding affinities, stoichiometries, and the enthalpy associated with binding were 
monitored using isothermal titration calorimetry (ITC) as previously described (Bradrick 
et al., 1996).  Briefly, measurements were carried out on a Microcal Omega 
Ultrasensitive Isothermal Titration Calorimeter equipped with a nanovoltmeter for 
improved sensitivity and connected to a circulating water bath for temperature control.  
The data were automatically collected by an IBM PC running DSCITC data acquisition 
software and were analyzed using Origin software provided by the manufacturer.  The 
design and operation of this instrument have been described by Wiseman et al. (1989).  
Unless otherwise indicated, samples typically consisted of ~90-100 µM tetramer in MTA 
buffer, pH 8.  For binary experiments monitoring NADPH as titrant, measurements were 
performed at 28oC.  Addition of ligand to buffer was performed to allow baseline 
corrections.  Binary data sets were fit to an interacting sites model where the 
stoichiometry of ligand binding was set equal to two.  For studying binding of folate to 
R67 DHFR-NADPH, experiments were performed at 13°C to minimize catalysis.  In 
these experiments, protein and NADPH were added to the sample cell at a 1:1 ratio.  This 
allows saturation of the first NADPH site.  Folate was then titrated into the sample until 
saturation was achieved.  The ternary data were fit to a single site model.  A minimum of 
two separate measurements were made for each titration.  
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Gel Filtration Studies  
 Gel filtration studies, at pH 5 and 8, were carried out at 4° C on a Pharmacia 
FPLC using a Superose 12 (HR 10-30) column with a flow rate of 1.0 ml/min.  The 
column was equilibrated in MTA buffer.  Standard curves at pH 5 and 8 were produced 
by plotting the log molecular weight of protein standards (Pharmacia Low Molecular 
weight calibration kit) versus Kav.  This allowed determination of the molecular weight 
and thus the oligomeric state of each R67 DHFR mutant.  The Kav is defined as: 
 
    Kav = (VE - VV)/(VB - VV)    (1) 
 
where VE is the elution volume, VV is the void volume, and VB is the bed volume of the 
column matrix. 
       
pH Titration of Tryptophan Fluorescence  
 To determine whether the active site mutations in this study affect the overall 
oligomeric structure, steady state tryptophan fluorescence analyzed on a Perkin Elmer 
LS-5B luminesence spectrometer was used to monitor the pH-dependent equilibrium 
between tetramer and two protonated dimers in either wild type or mutant R67 DHFRs 
given by the following equation (Nichols et al., 1993):  
 
     Koverall 
           T + 2nH+     ⇄    2DHn    (2) 
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where T is tetramer, DHn is protonated dimer, n is the number of protons and Koverall 
equals [T] [H]2n/[DHn]2.  The emission spectra for the DHFRs (excitation at 295 nm) 
were measured from 300 to 450 nm at each pH during the titrations.  The intensity 
averaged emission wavelength, <λ>, for each emission spectrum was calculated using the 
equation: 
 
    <λ> = Σ(Iiλi)/Σ(Ii)      (3) 
 
where I is intensity and λ is the wavelength (Royer et al., 1993).  <λ> is an integral 
measurement that is less sensitive to noise.  Data were fit to the following equation 
describing the linkage between the tetramer and protonated dimer equilibrium (Nichols et 
al., 1993):  
 
Fluobs = {( Fludi - Flutet) {[H]2n/(4KoverallPtot)} {-1 + [1 + 8    
 KoverallPtot/[H]2n)]1/2}} + Fludi     (4) 
 
where Koverall = ([T][H]2n)/DHn]2 in units of M, M2 or M3 for n = 1, 1.5 or 2 respectively; 
Fluobs is the observed fluorescence ; Fludi and Flutet are the calculated limits for dimer and 
tetramer fluorescence at low and high pH values; and Ptot is the total protein 
concentration in terms of dimer (Nichols et al., 1993).  SAS (statistical analysis software) 
was employed to fit the data using nonlinear regression.  To facilitate comparison, the 
data were normalized by fitting to Fapp = (Yobs - YpH 8)/(YpH 5 - YpH  8), where Fapp is a 
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fractional value between 0 and 1 and Yobs, YpH  8, and YpH  5 are the optical values 




The A36S, Y46F, Y46H, T51V, G64A, V66A and V66T R67 DHFR mutant 
genes were constructed and sequenced.  To evaluate which mutations were most 
functional, E. coli cells were transformed with plasmid DNA containing the mutant genes 
and screened for the ability to confer resistance to trimethoprim. Only Y46F, Y46H, 
V66A and V66T mutant genes provided resistance to the antibiotic at 20 µg/ml.  The 
A36S and T51A mutant genes did not confer resistance to TMP upon host E.coli.  As 
other mutants with this phenotype have resulted in a dimeric protein, we did not pursue 
these mutants further.  The Y46H and G64A mutants did confer TMP resistance, but 
protein yields were negligible.  
 
Steady State Kinetic Analysis 
Steady state kinetic data are presented in Table 3 for wt and mutant R67 DHFRs.  
All kinetic data were obtained at pH 7.  The kinetic values for Y46F R67 DHFR and the 
V66 mutants are comparable to those of wt R67 DHFR.  These results indicate that Y46 
and V66 residues either do not directly interact with either NADPH or DHF or if the 
interaction utilizes an intermediate water, the water position is not altered.  A third 
possibility is that if the proposed interaction uses backbone carbonyl interactions, that the 
substitution does not affect the backbone position.  For Y46 substitutions, the Y46F  
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Table 3.  A comparison of steady state kinetic values for R67 DHFR variants at pH 7.0.  
 
DHFR Species (pH 7) 
 
 
kcat    (s-1) 
 






Km (DHF) mutant 
÷ Km (DHF) wt 
 
Km (NADPH) mutant 
÷ Km (NADPH) wt 
Wt R67 DHFRa 1.3 ± 0.07 5.8 ± 0.02 3.0 ± 0.06 - - 
Y46F R67 DHFR 1.2 ± 0.06    7.0 ± 0.4 4.0 ± 0.20 1.2 1.3 
V66A R67 DHFR 1.4 ±  0.02 7.6 ± 0.01 6.3 ± 0.03 1.3 2.0 
V66T R67 DHFR 0.44 ± 0.004 4.0 ± 0.1 7.3 ± 0.20 0.7 2.4 
a Values from Reece et al., 1991
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mutant was conservative while the Y46H mutation was not.  The Y46H mutant 
expression levels were low and the protein possesses very little if any activity.    
 
Isothermal Titration Calorimetry 
 Isothermal titration calorimetry (ITC) measures the amount of heat released or 
absorbed upon ligand binding to a protein or other macromolecule.  To determine the 
effect of the mutations on ligand binding and cooperativity, isothermal titration 
calorimetry was employed to monitor NADPH binding to the Y46F and V66A DHFRs. 
Best fits of wt R67 DHFR data indicate it binds 2 NADPH molecules, with negative 
cooperativity (Bradrick et al., 1996).  Figure 2 shows a representative ITC titration 
between Y46F R67 DHFR and NADPH.  Best fit values are given in Table 4.  Also given 
in Table 4 is the difference in affinity between the 2 bound NADPH molecules.  The ratio 
of Kd2 to Kd1 for pairs of bound ligands clearly indicates that the Y46F and V66A 
mutations have minimal effects on the cooperativity between bound ligands.  This is 
apparent by the nearly identical values for these mutants and the wildtype enzyme.   
From previous studies it has been observed that titrating folate (a poor substrate of 
R67 DHFR) into a sample cell containing a 1:1 ratio of protein and NADPH results in an 
exothermic binding isotherm (Bradrick et al., 1996).  We have, therefore, used this 
method to monitor binding of folate to various mutant protein•NADPH complexes.  
Figure 3 shows a representative ITC titration for ternary complex formation between a 
1:1 mixture of Y46F R67 DHFR and NADPH titrated with folate.  ITC data for a series 
of mutants possessing different kcat values from both this study and the one previously 
described (Strader et al., 2001) are shown in Table 5.  This table includes the enthalpy  
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Figure 2.  ITC titration involving NADPH binding to Y46F R67 DHFR.  Panel A shows the 
series of peaks generated from the heat liberated upon NADPH binding.  As the protein 
approaches saturation, less of each subsequent addition is bound, so the peaks decrease in 
height.  The protein concentration was 92 µM tetramer.  Panel B shows the heat liberated 
per mol of titrant added vs. the cofactor/protein tetramer molar ratio. The smooth line shows 
the fit to the data for a model which describes ligand binding to two interacting sites 
exhibiting negative cooperativity.  Average values for Kd and ∆H values are given in Table 
4.  Note: the heat associated with the first peak in panel A was not included in panel B or in 
the data analysis. 


























0 50 100 150 200 250
A
B









Table 4.  A comparison of Kd values describing binding of NADPH to R67 DHFR 
variants at pH 8.0 monitored by ITC. The ITC fit reports microscopic constants (k1 and 
k2), however the Kd values below are the macroscopic constants (K1 and K2).  The 
statistical relationship between microscopic and macroscopic constants is Kd1 = ½ kd1 and 
Kd2 = 2 kd2 (Cantor and Schimmel, 1980).  Values reported for all mutants are fit to an 


















Wt R67 DHFRa 2.5 ± 0.15 
95 ± 4 
38 -8.6 ± 0.02 
-5.8 ± 2.5 
2 
Y46F R67 DHFR 6.0 ± 0.05 
116 ± 0.30 
20 -7.8 ± 0.06 
-5.3 ± 0.10 
2 
V66A R67 DHFR 3.2 ± 0.02 
119 ± 3.3 
37 -9.5 ± 0.07 
-6.6 ± 0.18 
2 
aFrom reference Bradrick et al., 1996 
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Figure 3.  Ternary complex formation between a 1:1 mixture of Y46F R67 DHFR and 
NADPH titrated with folate.  The initial protein concentration was 100 µM.  Although folate 
is a poor substrate for R67 DHFR, a limited amount of reduction of folate can take place.  
This experiment was carried out at 13 °C to minimize catalysis.  Panel A represents the 
series of peaks generated with each addition of ligand.  Panel B shows the heat liberated per 
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Table 5. A comparison of ITC values for titrating folate into a 1:1 mixture of enzyme and 
NADPH. This results in formation of the ternary complex.  Data were fit to a single sites 
model.  The ∆Hbinding corresponds to the enthalpy of folate binding.  The kcat values were 



















Wt R67 DHFRa -8.6 ± 0.02 11 ± 0.04 0.87 ± 0.02 4 
Y46F R67 DHFR -9.0 ± 0.30 14 ± 0.30 0.83 ± 0.02 4 
V66A R67 DHFR -9.8 ± 0.30 13 ± 0.05 0.75 ± 0.02 4 
Q67C R67 DHFRb -2.5 ± 0.40 98 ± 0.50 0.80 ± 0.07 4 
I68L R67 DHFRb -6.0 ± 0.60 70 ± 0.30 0.96 ± 0.13 4 
I68M R67 DHFRb -6.6 ± 0.50 89 ± 0.10 1.30 ± 0.08 4 
Y69F R67 DHFRb -5.0 ± 0.60 200 ± 0.80 1.30 ± 0.10 4 
aFrom Bradrick et al., 1996 










(∆H) associated with forming the ternary complex, Kd values and binding stoichiometry 
per tetramer.  From these data, differences in ∆H are seen for mutants with different kcat    
values.  For example Q67C R67 DHFR has a kcat of  0.10 s-1 and a heat of enthalpy 
corresponding to –2.4 kcal/mol.  Y46F R67 DHFR has a kcat value of 1.78 s-1 and a heat 
of enthalpy around -9.0 kcal/mol. 
 
Gel Filtration   
To test whether the mutations alter the active oligomeric state of the mutant R67 
DHFRs, their elution patterns at pH 5 and pH 8 were analyzed using molecular sieving 
chromatography.  Any changes in the oligomerization state towards dimer would 
decrease the catalytic activity of the enzyme.  Values corresponding to the estimated 
molecular weight of mutant and wt R67 DHFRs are shown in Table 6.  At pH 5.0, wt 
R67 DHFR elutes from an FPLC Superose 12 column as a dimer and at pH 8.0, it elutes 
as a tetramer.  The mutant proteins have similar estimated molecular weights as wt R67 
DHFR at pH 5.0 and 8.0.  The amino acid sequence predicts molecular weights of 16,860 
and 33,720 daltons for dimeric and tetrameric R67 DHFR (Nichols et al., 1993).  
Aberrant molecular weight estimates determined by gel filtration are not unusual and 
often occur because the elution is also affected by hydrodynamic volume or shape of the 



























Wt R67 DHFR 41,000 ± 280 26,000 ± 920 
Y46F R67 DHFR 43,700 ± 340 26,000 ± 300 










pH Titration of Tryptophan Fluorescence   
Steady state tryptophan fluorescence was monitored as a function of pH to 
examine any subtle effects the mutations may have on the tetramer to two dimers 
equilibrium.  Symmetry related H62, H162, H262 and H362 residues located at the dimer  
interfaces are involved in stabilizing tetrameric R67 DHFR.  Titration of these residues 
results in tetramer destabilization and protonated dimer formation.  Since W38 also 
occurs at the dimer-dimer interfaces, tryptophan fluorescence can be used to monitor 
whether the W38 environment is solvent exposed (dimer) or buried in a more 
hydrophobic environment (tetramer).  The pH titration data for wt, Y46F and V66A R67 
DHFRs are listed in Table 7.  The Koverall values for each mutant are similar to those for 
wt R67 DHFR with the best fit occurring when n = 1.5, where n corresponds to the 
number of protons added per dimer-dimer interface.  To aid in comparison, the data were 
converted to Fapp values and the profiles for the wt and Y46F mutant DHFRs are shown 
in Figure 4.  The data indicate that the Y46F and V66A mutations minimally perturb the 




Residues that compose the ligand binding surface of R67 DHFR  
The 222 symmetry of R67 DHFR combined with the single active site pore results 
in an unusual approach to catalysis.  Most enzymes possess active sites with ligand 
binding regions that display a high degree of specificity.  In such a scenario, mutations 











Figure 4. pH titration of R67 DHFRs monitored by steady state fluorescence. The 
intensity averaged wavelength (λ), for wt and Y46F R67 DHFRs, is plotted versus pH, 
where circles and squares represent wt and Y46F R67 DHFR, respectively. The protein 
concentration of wt and Y46F R67 DHFRs was 2 µM.  The data were each fit to equation 
4 and best fit values are listed in Table 7.  For ease of comparison, data were converted to 



































































Table 7.  Best Fit Values for the pH Dependent Dissociation of Tetramer ⇄ 2 Dimers as 
Monitored by Fluorescence. 
 
DHFR Species K overall (= Ka 2n / Kd) 
for n=3 in units of M2 
Wt R67 DHFR 1.2 x 10 –13 ± 4.0 x 10 –14 
Y46F R67 DHFR 9.3 x 10 –14 ± 2.1 x 10 -14 












example of this active site constellation is given by E.coli chromosomal DHFR (Miller et 
al., 1998).  Previous data of R67 DHFR mutants, however, indicate that key residues 
positioned near the center of symmetry display very little, if any, specificity for either 
cofactor or substrate and play a dual role in binding (Strader et al., 2001; Howell et al., 
2001).   
A36, Y46, T51, G64 and V66 were also predicted to contribute to ligand binding. 
Site directed mutagenesis was therefore employed to probe their potential roles in binding 
specificity and catalysis.  Because single mutations in the R67 DHFR gene result in four 
mutations per homotetramer, large cumulative effects on the ligand binding surface and 
overall structure can occur.  From the studies in this report, A36S and T51A mutant 
genes do not confer resistance to TMP while the G64A mutant protein has low expression 
levels.  φ and ψ angle calculations from the R67 DHFR crystal structure indicate that A36 
occupies β-strand B located near the dimer-dimer interface, while G64 is in the  i + 2 
position of another type II reverse turn.  Furthermore T51 is adjacent to a proline residue.  
Mutations at these residues could very well compromise the structural ability of the turn 
to form, leading to the TMP sensitive phenotype.  Only those mutants at residues Y46 
and V66 resulted in active proteins that could be characterized.     
The Y46 and V66 mutants did not alter kinetic or ITC values significantly, 
indicating these residues may not directly be involved in ligand binding. The crystal 
structure and proposed ternary model by Howell et al (2001) predict that V66 may 
interact with both ligands directly through backbone interactions.  These backbone 
interactions may involve an intermediary water as the crystal structure indicates that the 
backbone carbonyl of V66 positions a water within hydrogen bonding distance of the 
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pteridine N5 atom.   An alternative explanation is that the substitution is not sufficient to 
perturb these interactions and as a result ligand binding and catalysis are not changed.  
 
How does R67 DHFR compare with E.coli chromosomal DHFR?  
Although crystal structure, NMR, computational docking, ITC and steady state 
kinetic data have allowed an understanding of both the active site location and binding 
mechanism, the exact strategy of how R67 DHFR enhances the rate of catalysis is still 
unclear.  To date, crystal structures representing only the apoenzyme and a partially 
characterized folate bound binary complex have been resolved.  On the other hand, a 
wealth of crystallographic, NMR, kinetic, and molecular dynamics data have been used 
to elucidate the structure as well as a full kinetics pathway describing how ligands bind in 
E. coli chromosomal DHFR and how molecular motions may be involved in catalysis 
(Sawaya et al., 1997; Fierke et al., 1987; Osborne et al., 2001; Agarwal et al., 2002; 
Radkiewicz et al., 2000).  These studies therefore provide a good comparison for 
studying catalysis by R67 DHFR.    
E.coli chromosomal DHFR is a well evolved enzyme (Fierke et al., 1987) with a 
catalytic efficiency of 0.15.   This is close to 0.6 reported by Albery and Knowles for 
(“the perfect enzyme”) triose phosphate isomerase (Albery and Knowles, 1976).  E.coli 
DHFR also has an active site containing specific regions for binding either DHF or 
NADPH (Miller and Benkovic., 1998) and undergoes ligand induced conformational 
changes involving subdomain rotation and alternate active site loop conformations that 
may be involved in specificity and catalytic efficiency (Sawaya et al. 1997; Radkiewicz 
et al., 2000).  Another important feature of bacterial chromosomal DHFRs is that they 
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possess a conserved aspartic acid proposed to be involved in reaching the transition state 
by several possible mechanisms. These include general acid catalysis (Howell et al., 
1986), raising the N5 pKa of DHF to 6.5 under ternary conditions (Chen et al., 1994), 
facilitating enol tautomerization in DHF (Lee et. al., 1996) or a way to polarize DHF 
(Casarotto et al., 1999).  Hydride transfer is very efficient in the chromosomal enzyme as 
the rate limiting step is product release (Fierke et al., 1987).    
Previous data indicate that R67 DHFR has a very different active site 
constellation than the E.coli chromosomal DHFR (Strader et al., 2001; Howell et al., 
2001; Narayana et al., 1995; Li et al., 2001).  The folate-binary crystal structure, kinetic 
data and computational ternary model indicate that the central pore active site (due to the 
222 symmetry) is composed of several residues that bind either ligand with very little, if 
any, specificity.  Furthermore, disulfide cross-linking in an H62C mutant and subsequent 
pH profile analysis indicates that R67 DHFR does not possess a proton donor equivalent 
to the conserved aspartic acid residue.  NADPD isotope effects indicate hydride transfer 
to be rate limiting in R67 DHFR (Park et al., 1997).    
 
Does R67 DHFR have a different catalytic strategy than the chromosomal enzyme? 
The 222 symmetry of the structure, the single active site pore and lack of a 
suitable general acid catalyst clearly indicate that R67 DHFR provides a very different 
catalytic strategy than chromosomal DHFR.  Because of these features, R67 DHFR may 
be an ideal model of a primitive enzyme that has not yet been optimized by evolution.   
Catalysis can be profoundly affected by mutations in the R67 DHFR gene because a 
consequence of the 222 symmetry is the presence of four mutations in the single active 
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site pore.  Therefore it is difficult for this enzyme to acquire mutations that facilitate 
catalysis and evolve to a higher efficiency.  This raises an important question; What is the 
basic strategy utilized by this enzyme to enhance the rate of hydride transfer and 
ultimately the formation of product? 
Our studies have indicated that the active site utilizes an electrostatic potential 
(personal communication with Stephanie Hicks) and a series of residues (and their 
symmetry related partners) that provide a hotspot surface to bind ligands (Howell et al., 
2001; Strader et al., 2001).  Enzymes most often enhance the rate of reaction by 
providing general acids/general bases/nucleophiles to aid catalysis and by binding ligands 
in an appropriate orientation that will stabilize the transition state (Fersht, 2000).  
Because R67 DHFR does not have a proton donor, it must have a simple approach to 
catalysis.  ITC, kinetic and computational data indicate that R67 DHFR has a “one site 
fits both” binding strategy in which three possible combinations of bound ligands have 
been observed.  One of these leads to catalysis while the other 2 nonproductive 
complexes (2 NADPH and 2 DHF) block the active site pore.  Interligand interactions, 
therefore, appear important in this enzyme and provide an alternate route to formation of 
the transition state. 
ITC experiments may allow evaluation of the above hypothesis by monitoring the 
enthalpy associated with binding folate to R67 DHFR•NADPH. A trend noted is a 
possible linear correlation between ∆H and kcat in a semi-log plot (see  Figure 5).  Data 
for other mutants in the active site pore were collected and plotted.  With the exception of 
the Y69F mutant, these data are consistent with higher kcat values being associated with 






Figure 5.  A potential linear correlation between the heat of enthalpy upon binding of 
folate to R67 DHFR•NADPH and log kcat.  The experiments were monitored by ITC 
using a 1:1 mixture of mutant R67 DHFR and NADPH.  The point corresponding to Y69F 
R67 DHFR (open triangle) was not used to fit the line that was drawn through the data. The 
initial protein concentration was 100 µM. Although folate is a poor substrate for R67 
DHFR, a limited amount of reduction of folate can take place.  This experiment was, 






















enzyme crystal structure with that of the binary folate•R67 DHFR complex suggests that 
conformational changes do not occur when ligands bind (Narayana et al., 1995).  Taken 
together with the ITC data, these results suggest that an enthalpic basis may be associated 
with positive cooperativity between NADPH and folate in binding.  Increased 
exothermicity is proposed to be associated with non-covalent interactions that result in a 
tighter interface or closer contact distances (Calderone et al., 2001).  The kcat values for 
various mutants may therefore be correlated with interligand contact distance, assuming 
no large change in orientation. 
Analysis of Figure 5 indicates that the heat of enthalpy associated with forming 
the productive ternary complex in Y69F R67 DHFR does not appear to correlate with its 
kcat value as do the other mutants.  All other mutants measured (Y46F, I68L, V66A) have 
similar Kd and Km values for NADPH as does wildtype R67 DHFR.  Since Y69F R67 
DHFR has different Kd and Km values for NADPH, it may bind this ligand differently.   
This proposal is supported by recent studies performed in our laboratory 
involving the contribution of ionic strength on ligand binding and catalysis (Hicks et al., 
manuscript submitted).  In these studies, quantitation of salt effects by calculating the 
slope of a log ionic strength vs. log Kd plot indicates that two ionic interactions are 
involved in binding NADPH in the ground state.  Interestingly, when analyzing salt 
effects on kcat/Km for both ligands, the slopes of log ionic strength vs. log kcat/Km plots 
indicate that one ionic interaction is lost in forming the transition state.  With these data 
in mind, the lack of correlation between kcat and the heat of enthalpy associated with 
forming the productive ternary complex in Y69F R67 DHFR may be correlated with the 
observed salt effect.  A model for this would involve an edgewise interaction between the 
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partial positive charge of the aromatic ring and the negatively charged pyrophosphate 
bridge of NADPH.  The partial charge arises from the quadrupole associated with 
aromatic rings (Doughtery, 1996).  Precedure for a salt effect on this type of interaction 
arises from Olson et al. (2001).     
Interestingly, when plotting log kcat/Km versus ∆H (see Figure 5), the data points 
corresponding to Y69F R67 DHFR are not outliers.  In these plots, all the points indicate 
a linear correlation between kcat/Km and heat of enthalpy upon binding of folate to R67 
DHFR ground state complexes.  Furthermore, the fact that the Y69F data points fit these 
lines better suggests that kcat/Km measures a more complete description of the reaction, 
including the binding components.  That the Y69F data point fits here but not in the log 
kcat versus ∆H plot may suggest it plays a role in proceeding from either the R67 
DHFR•NADPH or R67 DHFR•DHF complex to the transition state.  
 
Molecular dynamic studies and their implications 
An enthalpic basis for enzyme catalysis has been recently suggested by the use of 
molecular dynamic (MD) simulations.  Bruice and Benkovic (2000) have recently 
reviewed the use of molecular dynamics to study the relationship between the geometry 
of bound ligands (sampling the conformational space of an E-S complex) and catalytic 
efficiency (kcat/Km).  The data from these studies indicate that reaction rate is proportional 
to the population of near attack conformers (NACs, which closely resemble the geometry 
of the transition state).  NACs are conformers the ground state must pass through to enter 
the transition state.  They, therefore, facilitate the formation of a chemical transition state.  
The distribution of NACs depends on the extent of preorganization of the active site  
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Figure 6.  A potential linear correlation between the heat of enthalpy for binding of folate 
to R67 DHFR•NADPH and log kcat/Km.  Panel A describes the correlation for 
kcat/KmNADPH while Panel B does for kcat/KmDHF.  Because increased exothermicity is 
proposed to be involved in close contact distance, these data suggest that kcat/Km values 
for various mutants may be correlated with interligand contact distance assuming no 
major changes in orientation. The experiments were monitored by ITC using a 1:1 
mixture of mutant R67 DHFR and NADPH.  The initial protein concentration was 100 
µM. Although folate is a poor substrate for R67 DHFR, a limited amount of reduction of 
folate can take place.  This experiment was, therefore, carried out at 13°C to minimize 
catalysis.  













































































which they hypothesize correlates with enthalpy.  One particular example, cited in the 
review, involves studies of single mutants for horse liver alcohol dehydrogenase in which 
the “bulky” active site residue (Val 203) was replaced with smaller residues (Bahnson et 
al., 1993., Luo et al., 1999).  The data from these studies indicate a decrease in log 
kcat/Km with increasing MD-derived contact distance between reactants.  The bulky side  
chain, therefore, reduced the distance between the reactants (increasing exothermicity) 
and in the process increased the population of NACs.  These results suggest a correlation 
between catalytic efficiency and contact distance.   
Since preorganization of the enzyme active site is crucial in formation of NACs, a 
question that comes to mind is; Does R67 DHFR utilize interligand interactions to 
preorganize the reactants in order to facilitate formation of NACs?  The data in the 
kcat/Km plot support this idea, as a correlation between ground state binding and catalytic 
efficiency is observed.  If a more negative ∆H value correlates with a shorter contact 
distance, then the wildtype enzyme has evolved to provide a reasonable approach to 
catalyzing the DHFR reaction using this scaffold.  A component in the reaction is 
utilization of interligand interactions to bring the ligands in close proximity to provide the 
preorganization necessary for facilitating the formation of NACs.   
This proposal is further supported by interligand NOE NMR data (Li et al., 2001) 
and docking studies by Howell et al. (2001) which are consistent with the hypothesis that 
ligands in the active site of R67 DHFR adopt an endo transition state (where the 
nicotinamide ring overlaps the more bulky side of the pteridine ring) rather than the exo 
conformer (with minimal overlap of the 2 ligands).  Ab initio computer calculations 
indicate this endo transition state to be 2-8 kcal/mol more stable than the exo conformer 
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(that describes the transition state for chromosomal DHFR) due to inter-ligand 
interactions (Andres et al., 1996; Castillo et al., 1999).  These data, therefore, support our 
proposal that interligand interactions are critical for binding and subsequent formation of 
the transition state.  
The concept of preorganization is used by Benkovic and Bruice to suggest 
enzymes have a structural organization that leads to ground state NAC populations 
approaching unity (Benkovic and Bruice; 2000).  This makes sense because NACs 
resemble the transition state, and it is widely accepted that enzymes with high catalytic 
efficiency (an example is orotidine 5’- monophosphate decarboxylase) utilize a polar 
preoganized environment to stabilize the transition state (Warshel et al., 2001).  Because 
R67 DHFR is not very well evolved, it may compensate by using interligand interactions 
to reach the more stable endo transition state.  
 
Conclusions 
The E.coli chromosomal DHFR is a well-evolved enzyme with a remarkable 
catalytic efficiency.  It has all the “bells and whistles” that R67 DHFR lacks.  It therefore 
does not use the same simple strategy for catalysis.  Since binding and catalysis are 
separate steps in the chromosomal enzyme, we would not particularly expect to observe 
any linear correlation in a log kcat/Km versus ∆H plot.   
Recent data generated in our laboratory suggest that the R67 DHFR active site 
utilizes both an electrostatic potential (personal communication with Stephanie Hicks) 
and a series of residues that provide a hotspot surface to bind ligands (Howell et al., 
2001; Strader et al., 2001).  Because R67 DHFR possesses a single active site pore 
 106
displaying 222 symmetry, formation of 2 nonproductive complexes and does not have a 
proton donor, it must have a simple approach to catalysis.  The ITC data generated by 
monitoring the enthalpy associated with binding folate to R67 DHFR•NADPH implicate 
an enthalpic basis for the observed cooperativity and are consistent with higher kcat/Km 
values being associated with increasing exothermicity.  These data are further supported 
by the recent studies involving molecular dynamic simulations implicating that the 
preorganization of an enzyme active site and interatomic distances between reactants 
facilitate the formation of NACs (Bahnson et al., 1993; Bruice and Benkovic, 2000).  
Because the kcat/Km of R67 DHFR does not approach the diffusion limit and its active site 
is quite large and exposed to solvent, this enzyme may use interligand interactions to 
bring the ligands in close enough proximity to provide a compensatory preorganization 
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Why study R67 DHFR? 
R67 DHFR is structurally or sequentially unlike any highly evolved chromosomal 
DHFR studied.  In fact, R67 DHFR does not share sequence homology with any known 
gene sequences identified to date.  Previously, it has been suggested that R67 DHFR may 
be an ideal model for a primitive enzyme due to its unusual oligomeric structure. This 
makes sense because the 222 symmetry of the active site pore makes evolving to a higher 
catalytic efficiency difficult.  Furthermore, a single active site pore with 222 symmetry 
dictates that R67 DHFR must bind ligands in an unusual way.  Because of these unique 
features, identifying which residues are involved in ligand binding and catalysis is 
essential in better understanding the hotspot surface R67 DHFR utilizes.  Furthermore, a 
comparison with chromosomal DHFR can aid in better understanding the catalytic 
strategy utilized by R67 DHFR. 
 
Which residues are involved in binding and catalysis? 
Identifying residues in the active site that are essential for ligand binding and 
catalysis in R67 DHFR is a first step towards this goal.  With the use of crystal structural 
data, computational docking studies using DOCK (docking based on van der Waals 
interactions; Kuntz et al., 1982; Shoichet et al., 1993) and SLIDE (docking based on H-
bond formation; Schnecke et al., 1998; Schnecke et al., 1999; Raymer et al., 1997) and 
identifying residues and atoms exposed in the internal cavity of R67 DHFR by CAST 
(Moult et al., 1999), several residues have been proposed to be involved in ligand 
binding.  These include K32, A36, Y46, T51, G64, S65, V66, Q67, I68 and Y69.  
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  To explore the potential ligand binding and catalytic roles of these amino acids, 
site directed mutagenesis was utilized.  The basic strategy was to incorporate 
substitutions at the residue of interest in order to create a range of effects on ligand 
binding and catalysis without compromising the structural stability of R67 DHFR.  The 
most common rule applied was to make substitutions that occupied similar van der Waals 
volumes yet had an obvious chemical distinction that could alter the predicted interaction.  
Depending on the active site residue, either non-conservative or conservative mutations 
were required to do this.  To screen for inactive mutant R67 DHFRs, E.coli cells 
containing the mutant genes were grown in the presence of TMP.  A TMP sensitive 
phenotype was consistent with either an inactive enzyme or one in which the 
homotetrameric structure was unstable.   
Mutants at positions K32, A36 and T51 all conferred TMP sensitivity.   K32 and 
A36 are located on the same β-strand positioned near the dimer-dimer interface.  
Furthermore, these residues are proximal to W38, which is in the dimer interface.   
Interestingly W38F, K32A, K32M and K32R R67 DHFRs have previously been 
determined to be inactive dimers (West et al., 2000; Hamilton, 1997; personal 
communication with Stephanie Hicks).  A36S R67 DHFR is most likely dimeric as well.  
Based on analyzing φ and ψ angles of amino acid residues in the R67 DHFR crystal 
structure, T51 precedes a proline residue involved in a type I turn.  A mutation at this 
residue position could, therefore, very likely compromise the ability of the turn to form, 
which could affect the stability of the mutant leading to the TMP sensitive phenotype.       
 Mutants at the other proposed positions provided TMP resistance.  With the 
exception of G64, all residue positions were mutated to give stable proteins that could be 
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studied.  φ and ψ angle calculations indicate that G64 follows a proline residue and 
occupies the i+ 2 position of a type II turn connecting β strands C and D.  A substitution 
to alanine, could therefore, reduce the flexibility required to adopt the appropriate φ and 
ψ angles necessary for forming the turn.  With this in mind, the resulting low expression 
level exhibited for G64A R67 DHFR most likely reflects a compromise in structural 
stability.         
Table 1 illustrates the different outcomes of conservative versus non-conservative 
substitutions for mutant R67 DHFRs and notes whether the gene confers TMP resistance 
or sensitivity.  Table 2 illustrates the effect on steady state parameters that both types of 
substitutions have on residues Q67, I68 and Y69.  The data from these tables indicate that 
non-conservative mutations have the most deleterious effect on structure and function.  
For example, the conservative I68L and I68M R67 DHFRs were both expressed at 
reasonable levels.  I68Q R67 DHFR, on the other hand, conferred TMP resistance at a 
low level and resulted in low expression.  Y69F and Y69H R67 DHFRs were both 
expressed at reasonably high levels.  The less conservative Y69H R67 DHFR mutant, 
however, had considerably weaker ligand binding affinity and very low activity 
(compared to other mutants).  Although a conservative mutation has not been generated 
for the Q67 residue position, it is clear from kinetic and ITC data presented in this study, 
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No inhibition and low activity 
Y69F: TMPR 
Y69H: TMPS  
Y69F: similar 
Y69H: 2 fold less 
*Values determined by total active site surface (Å2) from residues identified by the algorithm CAST.   













Table 2.  Effects on steady state kinetic data for conservative or non-conservative 
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Q67H: 6.8 fold lower 
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Y69F: 2 fold higher 
Y69H: 90 fold less 
*Values are relative to the kcat value of the wildtype enzyme. 







different than the wildtype enzyme.  A future study of interest would, therefore, be to 
characterize a conservative Q67 mutant (Q67N for example) to see if the kinetic 
parameters are less drastic and perhaps more like the wildtype enzyme.       
Interestingly, mutating residues Q67, I68 and Y69 result in drastic effects not seen 
for the other active site residues (Y46, S65, V66).  For example, when compared to the 
wildtype enzyme, Q67H (Park et al., 1997) and Q67C R67 DHFRs display altered 
binding affinities (for both ligands) and a reduction in kcat.  Furthermore, Q67H R67 
DHFR displays substantial cofactor and substrate inhibition.  Similarly, I68L and I68M 
R67 DHFRs display altered kinetic parameters and substrate inhibition. For Y69 
substitutions, the Y69F mutant was quite active and resulted in a 2-fold enhancement of 
kcat.  However, the Y69H mutation decreased kcat approximately 90 fold.  Collectively, 
these results indicate that residues corresponding to positions 67-69 are essential in 
stabilization of the transition state.   
 The inhibition patterns displayed by Q67 and I68 mutants indicate that the 
mutations  impart a change in the binding mechanism (see Figure 3; Chapter 1).  For 
Q67H R67 DHFR, both Km and kcat values are lower than seen in the wildtype enzyme.  
The catalytic efficiency, however, is only 2-fold less than the wildtype enzyme indicating 
that kcat and Km values are altered in a compensating manner.   The inhibition is possibly 
due to non-productive binding modes (resulting from tighter binding) competing against 
productive ternary complex formation.  It is possible, however, that the mutation alters 
the orientation of ligand binding in the active site. ITC data describing binding of only 
folate or NADPH to Q67H R67 DHFR also indicate tighter binding compared to the 
wildtype enzyme.  The tighter binding (causing inhibition) is likely due to ring stacking 
 119
interactions with the imidazole side chain of histidine that would be absent in the 
wildtype enzyme (Hakoshima et al., 1992; Sapse et al., 1992; Brocchieri and Karlin, 
1994).   
The substrate inhibition patterns of the I68 mutants are not as profound as those 
exhibited by Q67H R67 DHFR.  The steady state data for I68L and I68M R67 DHFRs 
indicate weaker binding affinity and even more profound decreases in kcat (when 
compared to the wildtype enzyme, the catalytic efficiencies for I68L and I68M R67 
DHFRs are 17 fold and 32 fold less respectively).  Furthermore, ITC data describing 
NADPH binding (these experiments have only been done for I68L R67 DHFR) indicate 
weaker binding affinity and negative cooperativity.  ITC data describing folate binding 
have not been successfully performed due to the high Kd values, but would be helpful to 
decipher whether changes in Kd values and/or cooperativity (compared to the wildtype 
enzyme) possibly account for the substrate inhibition pattern.    
An interesting question is; Why do the positions of Q67 and I68 correlate with 
inhibition effects?  This may be addressed by considering the location of each in the 
central pore.  Figure 1 shows a Connolly surface illustrating the position of each to be 
near the center of symmetry.  Q67 residues are located at the dimer interfaces and interact 
through hydrogen bonding to form contiguous surfaces that compose the ceiling and floor 
of the pore.  Likewise, the two I68 residues also form contiguous surfaces by interacting 
with each other on the “right-hand side” and “left-hand side” of the pore.  This 
contiguous surface reduces the diameter of the pore and facilitates ligand binding near the 
center of symmetry allowing the substrate and cofactor rings to interact in an orientation 
leading to catalysis. 
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Figure 1: The connolly surface of R67 DHFR.  Panel A show the tetramer cut in half 
along the monomer-monomer interfaces, generating intact dimer-dimer interfaces (only 
one interface is shown).  Panel B shows the tetramer cut in half along the dimer-dimer 
interfaces; thus the monomer-monomer interfaces are intact.  The orientation is related to 
that shown in the top panel by 90º rotation along the y-axis.  The large orange regions (in 
both panels) arise from surface areas corresponding to residue Q67.  The red regions 





Crystal structural data support the center of the pore as important in ligand 
binding as the R67 DHFR complex describing bound folate indicates the pteridine rings 
of folate bind in the center of the pore with their rings overlapping (Narayana et al., 
1995).  Furthermore, ILOE (Interligand Overhauser Effects) NMR studies involving a 
suitable mimic of the ternary complex (NADP+ and 2-deamino-2-methyl-5,8-
dideazafolate) indicate that both ligands extend in opposite directions parallel to the long 
axis of the active site pore, and that the nicotinamide and pterin ring systems stack near 
the center (Li et al., 2001).  Together these data indicate that ligand binding occurs in the 
center of the active site pore and involves a substantial degree of ring stacking.  
When the location of residues where mutations lead to substrate and/or cofactor 
inhibition (illustrated in Figure 1) is compared with the structural data for the 2 folate and 
NADP+•2-deamino-2-methyl-5,8-dideazafolate complexes, a correlation can be seen.  
Q67 and I68 appear to stabilize transition state binding at the center of the pore and help 
discriminate against formation of the NADPH•NADPH and DHF•DHF complexes. 
Substitutions at these positions, therefore, can compromise this discrimination leading to 
formation of the nonproductive complexes and ultimately inhibition.    
This proposal is supported by recent studies performed in our laboratory utilizing 
a quadruplicated gene strategy to insert asymmetric mutations into R67 DHFR (Smiley et 
al., in press).  By inserting asymmetric Q67H mutations (into a tandem array of 4 R67 
DHFR genes linked in frame), it was found that the presence of 1 or 2 Q67H mutations in 
the quadruplicated gene product had little effect on kcat, but 3 or more mutations resulted 
in profound cofactor and substrate inhibition.  Furthermore, ITC data indicated that 
NADPH and DHF binding events under binary conditions were both tighter (for a 
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quadruplicated R67 DHFR with 3 Q67H mutations), while mutations had little effect on 
monitoring the heat of enthalpy upon forming a ternary complex.  The conclusion from 
these studies was that while Q67 appears to play a minimal role in formation of the 
NADPH•DHF complex, it appeared more active in discriminating against formation of 
the non-productive NADPH•NADPH and DHF•DHF complexes. 
 
What residues make up the hotspot surface of R67 DHFR? 
From the research in this thesis and other data generated from our laboratory, 
K32, Q67, I68 and Y69 appear to be the most important residues involved in ligand 
binding and catalysis.  First, Delphi predictions (computational method that solves the 
Poisson-Boltzman equation for solute molecules with complex structure; Honig and 
Nichols.,1995) indicate positively charged K32 residues create a positive electrostatic 
potential in the active site pore that serves to attract the negatively charged cofactor and 
substrate (Howell et al., 2001).  The role of K32 is further supported by salt effect studies 
indicating this residue forms ionic contacts with both ligands (Hicks et al., manuscript 
submitted).  Second, steady-state kinetic and ITC data clearly indicate that mutations at 
residue positions Q67, I68 and Y69 result in profound changes in both ligand binding 
affinity and catalysis.  Finally, mutations at positions Y46, S65 or V66 (with the 
exception of Y46H) result in mutants with nearly identical catalytic efficiencies as the 
wildtype enzyme.  A question that comes to mind is: Why do salt effects and mutations at 
residue positions Q67, I68 and Y69 result in such drastic changes?   
Analysis of Table 1 indicates that residues K32, Q67, I68 and Y69 contribute only 
40% of the ligand binding surface as determined by the algorithm CAST.  This program 
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identifies a total of 17 residues exposed in the active site pore of R67 DHFR as indicated 
by Table 2 from chapter 3.  Likewise, the surface area contributed by the active site 
residues Y46, S65 and V66 total only 17%. Taken together with the kinetic and ITC data, 
the contiguous location of K32, Q67, I68 and Y69 indicate their importance.  
This idea is further substantiated by the fact that Y46, S65 and V66 mutant R67 
DHFRs have nearly identical kinetic and ligand binding behavior (ITC) to the wildtype 
enzyme. While docking studies implicate S65 in forming side-chain hydrogen-bonding 
interactions with cofactor, V66 in interacting with both cofactor and substrate through 
backbone interactions and Y46 in interacting with substrate through hydrogen bond 
interactions involving its sidechain hydroxyl, the kinetic and ITC data indicate that these 
residues are not important in ligand binding.  A caveat may be that if water mediates the 
interactions, the water structure may not be sufficiently altered to affect binding. 
Analysis of Figure 2 indicates the surface areas of K32, Q67, I68 and Y69 
(represented by the color cyan) compose a continuous strip that runs from one edge of the 
pore to the other.  While residues Q67, I68 and Y69 would be expected to be next to each 
other, the contiguous placement of K32 in this strip supports its importance.  From the 
kinetic and binding data collected in our laboratory, the continuous strip occupied by the 
residues K32, Q67, I68 and Y69 appears to be the surface that R67 DHFR utilizes to bind 
both ligands.  The surfaces for Y46, S65 and V66 also form contiguous clusters (shown 
in magenta) suggesting these residues are not directly involved in ligand binding.  Again, 





































Figure 2: The Connolly surface of R67 DHFR.  Panel A shows the tetramer cut in half 
along the monomer-monomer interfaces, generating intact dimer-dimer interfaces (only 
one interface is shown).  The image in Panel B shows the tetramer cut in half along the 
dimer-dimer interfaces; thus the monomer-monomer interfaces are intact.  The large, 
continuous cyan regions (in both panels) in the center arise from surface areas 
corresponding to residues K32, Q67, I68 and Y69.  The magenta regions correspond to 
surface areas from residues Y46, S65 and V66.  The green regions correspond to surface 




contiguous, the addition of Y46 to this surface, suggests this area is not involved in 
ligand binding. 
Although our work has provided a good framework for understanding the hotspot 
surface R67 DHFR utilizes, an X-ray crystal structure of the ternary complex would 
provide the most definitive identification of all the residues involved in ligand binding for  
R67 DHFR.  For example, the structural positions of A36, T51 and G64 prevent the use 
of site directed mutagenesis studies to probe the role these residues may have in ligand 
binding and catalysis.  These residue positions may, however, be studied by engineering 
asymmetric mutations in the quadruplicated gene.   
 
Does R67 DHFR have a different catalytic strategy than the chromosomal enzyme? 
Several features, including its unique 222 symmetry, a single active site pore, the 
ability of 2 non-productive complexes to form, and lack of a proton donor, clearly 
indicate that R67 DHFR is not a well evolved enzyme.  R67 DHFR, therefore, provides a 
simple approach to catalysis that differs significantly from that of the chromosomal 
DHFR.  An interesting consequence of the 222 symmetry is that mutations in the gene 
sequence result in the presence of four symmetry related mutations which can have 
profound effects on catalysis.  It is, therefore, difficult for this enzyme to acquire 
mutations that facilitate catalysis and evolve to a higher efficiency.  A question is, 
therefore raised; How does R67 DHFR deal with these limitations to stabilize the 
transition state and ultimately facilitate catalysis? 
The most recent data generated in this lab indicates that interligand interactions 
may play an important role in catalysis.  This hypothesis arose as possible linear 
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correlations between ∆H with both kcat and kcat/Km, were observed.  This trend is also 
evident when analyzing the data for the Q67H homotetramer.  Because the Q67H kinetic 
data were obtained at pH 8 (due to cofactor and substrate inhibition), only 2 points are 
compared.  Figure 4, in panel A, shows a ∆H versus kcat semi-log plot with the Q67H data 
and the data from chapter 3 plotted together.  Interestingly, both data show a similar 
trend, further suggesting an enthalpic basis for catalysis.      
To further substantiate this possible trend, ITC data (collected by Derike Smiley) 
monitoring the enthalpy associated with DHF binding to various NADP+•quadruple 
Q67H asymmetric mutants were also analyzed.  The NADP+•DHF complex is also a 
reasonable mimic of the productive ternary complex although different from the 
NADPH•folate complex used in this study.  Figure 4, in panel B, shows semi-log plots 
for ∆H versus kcat presented in this thesis and for various quadruple asymmetric Q67H 
mutants.  Interestingly, both indicate a possible correlation between ∆H and kcat.  When 
plotting ∆H versus kcat/Km, however (as seen in figure 5) a possible correlation was only 
observed for the semi-log plot corresponding to DHF binding.  The plot corresponding to 
cofactor shows no trend.  
The additional plots indicate that more data should be accumulated to either 
support or refute these trends.  For example, the ∆H versus kcat plot shown in chapter 3 
looks promising but the point corresponding to Y69F R67 DHFR does not  appear to fit. 







Figure 4.  A potential linear correlation between the heat of enthalpy upon binding of folate 
to R67 DHFR•NADPH and log kcat (Panel A) or binding of DHF to Quadruplicated R67 
DHFR•NADP+ (Panel B).  Closed triangles in panel A correspond to wt and Q67H R67 
DHFRs in which the plotted kcat values were done at pH 8.  The open triangle in panel A 
corresponds to Y69F R67 DHFR.  This data point was not used to fit the line that was drawn 
through the data. Experiments in Panel A were monitored by ITC using a 1:1 mixture of 
mutant R67 DHFR and NADPH.  Although folate is a poor substrate for R67 DHFR, a 
limited amount of reduction of folate can take place.  This experiment was, therefore, 
carried out at 13°C to minimize catalysis.  Experiments for Panel B were monitored  by ITC 
using a 1:1 mixture of Quadruplicated R67 DHFR•NADP+.  These experiments were 
carried out at 28°.  
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Figure 5.  Semi-log plots of ∆H observed for binding of DHF to various quadruplicated 
R67 DHFR•NADP+ complexes and log kcat/Km for both ligands.  Panel A corresponds to 
kcat/Km for cofactor.  Panel B corresponds to kcat/Km for DHF.  Only the plot in panel B 
indicates a possible correlation.  Experiments were monitored by ITC using a 1:1 mixture 
of Quadruplicated R67 DHFR•NADP+.  These experiments were carried out at 28°.  The 
initial protein concentration was 100 µM.  
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in studying other mutants to better evaluate this possible trend.  Potential mutants include 
a T51S mutant, a K33M mutant (from Stephanie Hicks) and other asymmetric mutants 
from the quadruplicated gene construct.  Finally, we are also interested in performing 
these studies at various ionic strengths.  It was observed that although binding affinity in 
wt R67 DHFR was decreased with increasing salt concentration, the kcat value (Hicks et 
al., manuscript in preparation) increases.  We would, therefore, like to see how salt 
affects ∆H (for folate binding to NADPH•R67 DHFR).  Interestingly, a comparison of a 
log ionic strength versus log kcat plot or log kcat/Km for both ligands  indicates 1 
interaction is involved in going from the ground state complex to the transition state 
while plots of log Km vs log ionic strength indicate 2 interactions are involved in binding 
DHF or NADPH.  While increasing salt concentration typically decreases enthalpic 
effects, it will be interesting to see if loss of an ionic interaction in the ground state is 
compensated by other effects (such as ring stacking) that are reflected in the enthalpy of 
folate binding to wt R67 DHFR•NADPH.  
 
Conclusion and Future directions 
 Both the studies presented in this thesis and those performed in our lab have 
provided a suitable framework for better understanding how R67 DHFR utilizes 
symmetry to facilitate catalysis.  These data, taken together, identify the important 
residues composing the hotspot surface utilized by R67 DHFR to bind both ligands.  
Other studies, however, need to be performed to better understand the individual roles 
these residues may play in stabilizing the transition state.  For example, the strategy of 
inserting asymmetric mutations into a quadruplicated gene provided valuable insight into 
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the role of how Q67 functions in discriminating against non-productive complexes and 
the productive ternary complex formation.  This strategy could therefore be utilized to 
identify the consequence of asymmetric mutations for other residues identified to be 
involved in ligand binding.  Furthermore, several residue positions (A36, T51 and G64) 
predicted to be involved in ligand binding are located in structural positions that prevent 
the use of site directed mutagenesis studies.  These residue positions may, however, be 
studied by engineering asymmetric mutations in the quadruplicated gene.  This would 
assume that the quadruplicated DHFR could accommodate 1-2 mutations.   
Finally, understanding exactly how this enzyme functions in terms of catalysis, 
and what its limitations are will provide a game plan for using the quadruplication 
strategy to engineer asymmetric mutations that will perhaps break the symmetry of the 
active site pore.  In such a scenario, binding maybe able to be optimized in such a way to 
gain specificity for a particular ligand in one half the pore while the other half of the pore 
preferentially binds the other ligand.  Increased specificity could potentially result in a 
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